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PREFACE 
MESSAGE FROM  
THE IDF DIRECTOR GENERAL 
This International Dairy Federation (IDF) Animal Health 
Report comprises 24 articles which provide a glimpse 
of noteworthy topics on member countries and current 
research within the field of animal care, antimicrobial 
resistance and farming practices. It offers an opportunity 
for those involved in the field to present their findings 
through innovative research and providing an update on 
progress achieved and lessons learned.
IDF’s work on animal health and welfare aligns with the 
efforts of international organizations (the World Health 
Organization, the Food and Agriculture Organization of 
the United Nations, the World Organisation for Animal 
Health and Codex), stakeholders and consumers. Healthy 
and productive dairy animals can contribute towards the 
provision of a safe, sufficient and nutritious food supply 
at a time of a rapidly increasing global population. 
We extend our thanks to the authors, whose written 
contributions have helped to add value to this scientific 
report through their insights and analysis.
Wishing you a great reading, 
Caroline Emond
IDF Director General 
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MESSAGE FROM THE CHAIR OF 
THE IDF STANDING COMMITTEE ON 
ANIMAL HEALTH AND WELFARE
The objective of our report is to inform the 
dairy sector about new developments in 
the field of animal health and welfare and 
their implications on disease prevention 
by considering aspects related to farm 
economics, food safety, human health and 
dairy technology.
Thanks to the expertise of our committee 
members, the IDF Guide on Good Animal 
Welfare Practices in Dairy Production is 
now revised to be in line with the latest 
standards by the OIE and ISO TS 34700 
and will be published soon. International 
guidance on this topic is important, not 
only to educate and inform the reader 
about measures for animal health and 
welfare, but it also serves as a practical 
guide to facilitate continuous improvement 
in animal welfare, and secure safe and 
for fair international trade, as compliance 
with international standards can help to 
facilitate cross border fair trade and avoid 
unnecessary technical barriers. 
Fostering good animal health is a driver 
which can help to reduce the need for 
antimicrobials. Healthy animals do not 
need antibiotics. Prudent use of antibiotics 
and minimising antimicrobial resistance 
(AMR) is important as diseased animals 
need proper treatment to secure good 
animal welfare. Several pieces of IDF 
work underline their reduction and optimal 
use and thus, the prevention of resistant 
microbes. Apart from contributing to 
minimising antimicrobial use in the 
international sphere, IDF also monitors 
AMR in mastitis and other relevant 
pathogens. The IDF gathers information 
on antimicrobial usage, provides guidance 
on mastitis detection and recommends 
good management practices on milking 
machine settings. The proper use of 
modern sensors is part of this work. The 
IDF supports restricting antimicrobials 
to prevent infection and not to promote 
growth. Antimicrobials should only be used 
to treat diseases when proper indications 
exist. In addition, IDF’s work on food 
safety is crucial to guarantee consumers’ 
health and in decreasing the risk of the 
spread of AMR into the human population. 
Biosecurity is overall important to avoid the 
spread of pathogens and AMR between 
both herds and animals, but also from 
human reservoirs to animals.
Finally, I would like to encourage you to 
attend the next IDF Mastitis Conference 
from 14–16 May 2019 in Copenhagen. 
It is a platform for experts to share their 
knowledge and insights on udder health 
and milk quality.
Dr Olav Østerås
Chair of the IDF Standing Committee 
on Animal Health and Welfare
 olav.osteras@tine.no
MESSAGE FROM THE 
SCIENTIFIC EDITORS
Dear Reader,
It is an honour to present the 12th edition 
of the IDF Animal Health Report. In this 
issue, we present articles on a wide range 
of subjects concerning animal welfare 
programmes, mastitis, use of antimicrobials 
and resistance, milk quality, reproduction 
and fertility. We wish all readers an 
interesting and informative read.
Dr Louise Winblad 
Member of IDF Sweden
 louise.winbladvonwalter@vxa.se
And 
Dr María Sánchez Mainar
IDF Science and Standards Manager
 msanchezmainar@fil-idf.org
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United States: National Dairy FARM Animal Care Program 
Accredited to International Standards Organization Animal 
Welfare Technical Standard 
The International Organization for 
Standardization’s (ISO) Technical 
Specification 34700 - Animal Welfare 
Management/General Requirements 
and Guidance for Organizations in the 
Food Supply Chain [1] was developed 
to evaluate animal welfare programs’ 
conformance to international standards 
for animal care established by the World 
Organization for Animal Health (OIE) 
[2]. ISO, an independent, international 
standards-setting body, worked with the 
OIE to assist farmers and animal welfare 
programs in implementing the OIE species-
specific animal welfare standards. The OIE, 
the World Trade Organization-recognized 
body for setting animal health and welfare 
standards affecting international trade, 
adopted dairy cattle welfare standards in 
2017 [2].
In the United States, the U.S. Department 
NEWS FROM IDF 
MEMBER COUNTRIES
Program materials evaluated
 FARM Animal Care Reference Manual
 FARM Animal Care Self-Assessment 
 FARM Animal Care Third-
Party Verification
 FARM Dairy Cattle Ethics 
and Training Agreement
 FARM Comprehensive 
Emergency Action Plan 
 FARM Veterinarian Client 
Patient Relationship Form
 FARM Herd Health Plan
 FARM Employee Training Resources
 FARM Proper Care for Non-
Ambulatory Animals Poster
 FARM Emergency Contact Poster
 FARM Top 11 Considerations 
for Culling Dairy Cattle Poster
 FARM Milk & Dairy Beef Residue 
Avoidance Reference Manual 
Table 1 – National Dairy FARM Animal Care 
Program materials evaluated for ISO Technical 
Specification 34700.
of Agriculture’s Agricultural Marketing 
Service [3] offers a voluntary marketing 
program which ensures independent 
welfare programs meet the specifications 
of the ISO Technical Specification 34700. 
In 2017, the National Dairy FARM Animal 
Care Program (administered by National 
Milk Producers Federation in conjunction 
with Dairy Management Incorporated) 
applied to USDA-AMS for accreditation 
with the ISO Technical Specification 34700 
[4]. 
The USDA-AMS has developed species-
specific audit tools to assess animal 
welfare programs for compliance with the 
ISO Technical Standard 34700 including 
QAD 1060A ISO TS Animal Welfare 
Management Checklist [5] and QAD 
1060C Animal Welfare and Dairy Cattle 
Production System Checklist [6]. The 
National Dairy FARM Animal Care Program 
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submitted all program materials, standards 
and guidelines to USDA-AMS (Table 1). 
USDA-AMS used these materials to audit 
the standards and program execution to 
the OIE requirements as outlined by ISO 
Technical Standard 34700. Additionally, an 
on-site audit of program implementation 
was conducted.
On 14 February, 2018, USDA-AMS affirmed 
that the FARM Animal Care Program is 
ISO Technical Standard 34700 compliant 
(Figure 1) which validates the design and 
implementation of the program [6]. The 
National Dairy FARM Program is now the 
first livestock animal care program in the 
world to be recognized internationally for its 
industry-leading animal welfare standards.
In achieving this compliance, US and 
international dairy customers can be 
assured that the dairy products coming 
from FARM Animal Care Program 
participants meet the stringent, 
internationally recognized animal welfare 
standards set by the OIE.
J. Jonker1, E. Stepp1, M. Gage2   
National Milk Producers Federation, 
United States, 2Gage Group 
Consulting, United States
 jjonker@nmpf.org
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”In the US, the National Dairy 
FARM Program is now the 
first livestock animal care 
program in the world to be 
recognized internationally 
for its industry-leading 
animal welfare standards.”  
Jamie Jonker
Official Listing of Approved USDA ISO Technical Specification 34700 Animal Welfare Assessment Programs
Company Program Name Program Scope Approval Information
National Milk Producers Federation
2107 Wilson Blvd. Suite 600
Arlington, VA 22201
Phone: (703) 469-2372
Contact: Emily Meredith
Email: emeredith@nmpf.org
National Dairy Farm 
Program
Animal Welfare and Dairy Cattle 
Production Systems
• QAD 1060C Animal Welfare and Dairy 
Cattle Production Systems Checklist
• QAD 1060A ISO TS Animal Welfare 
Management Checklist
Approval No. 
TS7286BAA
Effective Date: February 
14, 2018
Figure 1 – The National Dairy Farm Program as officially approved by the USDA ISO TS 34700 Animal Welfare Assessment Programs.
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France: an information website for dairy 
farmers on hoof health and lameness 
management in dairy herds
Lameness is, by its frequency and its 
economic importance, the 3rd disease 
in French dairy herds, after mastitis and 
reproductive issues. On the initiative of 
the CNIEL (French Dairy Board) and in 
collaboration with lameness experts* 
(veterinaries, hoof trimmers, technical 
advisors and experts from technical 
institutes), a French reference website 
on lameness has been developed. Online 
since September 2017, more than 13,000 
users have already connected to the 
website.
Designed for dairy farmers and their 
advisors, the website synthesizes all the 
current knowledge on lameness to help 
farmers prevent, recognize and manage 
lameness in their herds as quickly as 
possible: from the hoof anatomy to the 
lameness identification and treatment, 
through recording lame cows. The website 
is very educational, based on many photos 
and didactic videos, for example, on the 
fragility of the hoof or on lameness scoring 
(thanks to our colleagues at the VetSuisse, 
university of Zurich and Dairy NZ). 
The key issue of reduction of antibiotics in 
dairy farms and antimicrobial resistance is 
also addressed. It is accepted that each 
lesion is different and must be treated with 
appropriate treatment. The injection of an 
antibiotic is often useless (except for the 
interdigital phlegmon).
To ensure correct treatment and prevention 
of hoof lesion, a specific tool has been 
developed in order to help farmers identify 
the type of lameness. Based on a hoof 
diagram, the user selects the area affected 
by the lesion and identifies, using photos, 
the lesion on their cow. After recognition, 
farmers can learn more about the lesion 
selected: risk factors, treatment and 
prevention adapted to the lesion.
This information website is not intended to 
replace training for farmers on identifying 
lame cows and functional trimming, or the 
advice of lameness professionals (hoof 
trimmers, veterinarians ...).
E. Modric
Centre National Interprofessionnel de 
l’Économie Laitière (CNIEL), France
 emodric@cniel.com
REFERENCES
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”Designed for dairy farmers 
and their advisors, the 
website synthesizes all 
the current knowledge on 
lameness to help farmers 
prevent, recognize and 
manage lameness in their 
herds as quickly as possible. 
To ensure correct treatment 
and prevention of hoof 
lesion, a specific tool has 
been developed in order 
to help farmers identify 
the type of lameness.” 
Eloise Modric
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Norway: the Animal Welfare Index 
An example of application of OIE and ISO 
standard using the animal recording system
Animal welfare has had a great deal of 
attention over the last decade, both from 
consumers, retailers, the international 
community and farmers. National regu-
lators and International organisations like 
the International Dairy Federation (IDF), 
the World Organization for Animal Health 
(OIE) and the International Organization for 
Standardization (ISO) have put a lot of ef-
fort into producing regulations and guide-
lines on animal welfare and the focus is ev-
er-increasing. The Norwegian government 
published their first official act and regula-
tion on animal welfare in 1935, revised in 
1974 and again in 2009 [1]. The IDF pub-
lished the ‘Guide for good animal welfare 
in dairy production’ in 2008 following the 
OIE principles established in 2006 [2], with 
expert participation from the OIE and the 
Food and Agriculture Organization of the 
United Nations (FAO). The OIE adopted 
their standard on ‘Animal welfare in dairy 
cattle production systems’ in May 2016 [3] 
and ISO followed with the ISO standard 
‘Animal Welfare Management – General 
Requirements and Guidance for Organi-
zations in the Food Supply Chain’ in De-
cember 2016 [4]. The ISO TS 34700:2016 
reflects the OIE standard and aims to facil-
itate the implementation of the animal wel-
fare principles of the OIE Terrestrial Animal 
Health Code by the private sector.
Norway has a long tradition in animal re-
cording systems, such as milk yield, animal 
information (culling and death) and health 
and mortality records, both in dairy cat-
tle and calves. Approximately half of the 
variables indicated as output variables in 
the OIE welfare standard [3] are included 
in the Norwegian Dairy Herd Recording 
System (NDHRS) [5]. Using the NDHRS, it 
is possible to apply a statistical algorithm 
by calculating the normal standard devi-
ation (the number of standard deviations) 
for each herd on each variable. This herd 
specific normal standard deviation is thus 
the number of standard deviations away 
from the national mean, supposing a nor-
mal distribution, or a Poisson distribution 
for discrete events like disease. Using this 
index, many of the parameters described 
on OIE welfare standard can range from 
+3 to -3. Figures above or below those are 
truncated to +3 or -3 respectively. Finally, 
these figures are added up to a herd ani-
mal welfare index which is adjusted so that 
the mean is around 100. The main area 
included in this index are variables with-
in; claw health services, calf disease and 
mortality, mortality in dairy cows, dehorn-
ing routines in calves, young stock health 
(mortality, disease, growth rate and age at 
first calving), fertility (number of days from 
first to last insemination and calving inter-
val), udder health (clinical mastitis and cell 
count), metabolic diseases, culling reasons 
and longevity, milk production difference 
between 1st, 2nd and above 2nd calving. 
One example of the distribution of this wel-
fare index is illustrated in Figure 1.
This index could be presented to the farm-
ers and advisors and could also be broken 
down into sub-indexes according to the 
main areas mentioned above. The point is 
that farmers and advisors could work on 
improvements within those areas. 
Some of the key areas are not included 
in this index. This might be aspects such 
as emotional areas and ‘natural life’, free-
dom to move, pasturing, fright indicators, 
cleanliness, play, access to water and feed, 
wounds and so on. These variables could 
be gathered yearly during farm audits. As 
the welfare index is available on the inter-
net, the farmer and advisor can easily con-
centrate on what is important.
Currently, the Norwegian dairy industry is 
building up some advisory services based 
on this index. This service might be part 
of the industries ISO TS 34700 standard. 
At present, the Norwegian dairy industry 
is working on providing information to the 
farmers and building up awareness and 
changing attitudes to increase the impor-
tance and understanding of good animal 
welfare in dairy production. Traditionally, 
Norway has very good records on health 
and cell count, but there is always varia-
tion, as Figure 1 illustrates. And, as long 
as there is variation there is also room for 
improvement. The key with the index is to 
document the status, provide a tool for im-
provement and measure the improvement.
To conclude, the animal welfare index is 
a good, objective tool to document and 
improve the animal welfare of dairy cattle 
in Norway. The tool is devised to improve 
the standard in all herds and can give spe-
cific professional advice to help farmers 
with even the lowest standard to progress, 
change their attitudes and inspire to be 
better. The index is combined with an ob-
ligatory herd audit at least once a year.
O. Østerås, DVM, PhD
TINE Norwegian Dairy, Norway
 olav.osteras@tine.no
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“The animal welfare index 
is a good, objective tool 
to document and improve 
the animal welfare of 
dairy cattle in Norway. 
As the welfare index is 
available on the internet, 
the farmer and advisor 
can easily concentrate 
on what is important.” 
Olav Østerås
Figure 1: Distribution of the Norwegian animal 
welfare index.
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Australia: promoting prudent use of 
antibiotics when drying off cows in 
Australian dairy herds
Antibiotics play an important role in 
dairy animal health and it is vital that 
farmers have continued access to 
effective medicines in order to protect 
the health, welfare and productivity of 
their herds. However, there is worldwide 
concern about the growing incidence of 
antimicrobial resistance (AMR) in both 
human and animal pathogens. Sustainable 
and responsible use of antimicrobials is 
critical to mitigate AMR and contribute to 
the ‘One Health’ strategies for AMR.
Although there is relatively low usage 
of antibiotics on our dairy farms, the 
Australian dairy industry is keen to play 
its part in ensuring that there will be a 
range of effective antimicrobial treatments 
available for future generations. Antibiotics 
used at drying off make up a large 
proportion of total dairy antibiotics used 
in Australian milking herds, so the dairy 
industry is encouraging farmers and dairy 
veterinarians to re-evaluate how antibiotic 
dry cow therapy is prescribed and used. 
Since the early 2000s, Dairy Australia’s 
Countdown extension project has been 
promoting best practices for milking 
and drying off cows to prevent and limit 
the impact of clinical and subclinical 
mastitis. The key activities include the 
flagship publication the Countdown Farm 
Guidelines [1] and the two-day Cups On 
Cups Off accredited training course for 
farm milking personnel. Instructional 
videos and waterproof visual guides [2] 
are also included as part of the extension 
resources to enable farmers to use these 
for on-the-job training and induction 
of new milking staff. These extension 
activities complement other Dairy 
Australia projects to enhance whole farm 
planning to manage biosecurity risks.
Countdown has recently developed 
a structured interview process which 
improves veterinary engagement with dairy 
farmers about the prescribing, dispensing 
and application of dry cow products. The 
Dry Cow Consult [3], a web-based tool, 
is designed to be used by farmers in 
conjunction with their veterinarian once a 
year. The farmer identifies the key risks for 
mastitis in their herd during the dry period 
and the veterinarian provides support 
for mastitis prevention and control with 
guidance levels for selective treatment of 
cows with antibiotic therapy. Planning the 
drying off process well in advance is a key 
element, to enable farmers to get all the 
following aspects right: cow identification 
and selection, milk production level, timing 
of drying off, product choice (internal teat 
sealant or antibiotic therapy), aseptic 
technique for product application and 
maintaining a low risk environment post 
drying off.
To further promote farmer adoption of the 
Dry Cow Consult, Countdown recently 
hosted a live webinar attended by over 140 
people, where the recommended approach 
to planning selective dry cow therapy 
was discussed, including the practical 
implications on farm. A recording of the 
webinar is now available for viewing here[4]. 
These new resources are underpinned 
by a series of technical reviews, the 
Countdown Technotes, based on a 
review of the scientific evidence, expert 
opinion and practical observations of 
the Australian dairy farming environment. 
Technotes 15, 16 and 17 are currently 
undergoing revision to reflect advances 
in our understanding of mastitis risks 
and management strategies during the 
dry period and post calving period. 
This suite of new Countdown resources 
aims to improve the confidence of farm 
veterinarians to advocate for more 
selective use of antibiotic dry cow therapy 
by dairy farmers at the time of drying off 
and will soon be published on the Dairy 
Australia website.
S. Tymms, K. Davis
Dairy Australia, Australia
 susannah.tymms@dairyaustralia.com.au
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“The Dry Cow Consult [3], a 
web-based tool, is designed 
to be used by farmers 
in conjunction with their 
veterinarian once a year.” 
Susannah Tymms
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Israel: Unusual Outbreak of Mastitis 
Caused by Methicillin-Resistant 
Staphylococcus aureus (MRSA) in a 
Dairy Herd in Winter 2018
Staphylococcus aureus is a leading cause 
of contagious bovine mastitis in many 
countries. In Israel it accounts for 2% of 
sub-clinical mastitis isolates and ~3% 
of clinical mastitis isolates, originating 
from bovine milk sent for bacteriological 
diagnosis to the Laboratory for Udder 
Health & Milk Quality (UHL). During 2017, 
62,300 milk samples were admitted to 
UHL for bacteriological diagnosis, and 
the results of clinical samples (25% of all 
samples) are presented in Figure 1.
Methicillin-Resistant Staphylococcus au-
reus (MRSA) is an emerging threat both 
to human and farm-animal industry health 
[1]. The prevalence of MRSA in milk sam-
ples originating from individual cows as 
well as from bulk-tanks has been moni-
tored by bacterial culture on MRSA-se-
lective chromogenic agar since 2011. The 
results from 2012 to 2018 are presented 
in Table 1.
The number of MRSA isolates has 
changed dramatically since February 
2018, when an increasing number of 
MRSA-positive milk samples originating 
from a specific farm were noted. This is 
a cooperative farm, with 1,050 lactating 
cows, using a 60-point rotary milking-
parlour, exhibiting relatively high mean 
DHI SCC (350,000 cells/mL). Results of 
diagnosis of milk samples originating from 
this farm are presented in Figure 2. By 
the end of June 2018, 13% of the cows 
(n=142) were infected with S. aureus, and 
98% of these isolates were diagnosed as 
MRSA. 
Antimicrobial susceptibility tests using the 
disk diffusion method indicated that all 
MRSA isolates were resistant to penicillin, 
oxacillin, cefoxitine, cefalexin/kanamycin 
and marbofloxacin; and susceptible to 
cefquinome, spectinomycin/lincomycin 
and rifaximine. Representative isolates 
”Methicillin-Resistant 
Staphylococcus aureus 
(MRSA) is an emerging 
threat both to human 
and farm-animal industry 
health. In Israel, by the 
end of June 2018, 13% 
of the cows (n=142) were 
infected with S. aureus, and 
98% of these isolates were 
diagnosed as MRSA.”
Falk Rama
Figure 1 – Distribution of pathogens isolated 
from milk clinical samples, 2017. 
Figure 2 – Accumulating number of cows 
diagnosed as MRSA-positive in milk samples 
originating from farm ‘M’ in the north of Israel, 
2018.
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Year No. TestedMilk Samples
No. S. aureus
Isolates
No. MRSA
Isolates No. infected herds
2012 54,600 628 1 1
2013 56,600 590 14 7
2014 53,000 632 2 2
2015 57,000 600 2 2
2016 54,000 747 4 2
2017 62,300 1,010 15 7
Table 1 – Total number of MRSA isolates from bovine mastitis in Israel, 2012–2017.
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were genotyped by PCR and sequencing 
and assigned to spa type t011, multi-
locus sequence type (MLST) CC398 and 
confirmed to be positive for mecA. These 
characteristics are typical to ‘livestock-
associated MRSA’ (LA-MRSA), a major 
cause of disease in a variety of livestock 
and humans, especially in Europe [2]. 
In addition to cows, two of the 12 farm 
workers were diagnosed as LA-MRSA 
nasal carriers by bacterial culture.
Here we report an exceptional outbreak 
of bovine mastitis caused by S. aureus 
in general, and specifically by MRSA, 
in Israel, where S. aureus prevalence in 
bovine mastitis is low. In this outbreak, 
LA-MRSA was detected in 142 cows. 
During 2018, LA-MRSA was diagnosed in 
another five farms in Israel; however, the 
records of diagnosed cows were much 
lower, ranging from 1–11 MRSA positive 
cows from herds ranging from 55 to 300 
cows.
Full molecular characterization of these 
isolates is on the way. 
R. Falk1, S. E. Blum2, A. 
Shwimmer3, S. Friedman1,3
1 Israel Dairy Board, Israel; 2 National 
Mastitis Reference Center, Israel; 
3 Israel Dairy Board, Israel
 rama@milk.org.il
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New Zealand: Update on 
Mycoplasma bovis situation 
on August 2018
Response Objectives Aim of Objective
1. Contain M. bovis to its known distribution 
in NZ 
Ensure that all feasible control options 
are maintained 
2. Assess feasibility of eradication Ensure eradication options are considered to the fullest possible extent
3. Determine and track distribution of M. 
bovis Inform decision making for this response 
4. Engage industry partners, stakeholders 
and Iwi and work with them to effectively 
manage this outbreak 
Work with, and through partners and 
stakeholders to achieve response 
objectives 
5. Maintain confidence in New Zealand’s 
biosecurity system and protection of 
conservation values 
Identify all partners and stakeholders in 
this response to effectively coordinate 
efforts 
6. Ensure that the welfare of affected 
farmer(s) and their livestock is effectively 
managed 
Minimise business disruption and 
emotional distress. 
Table 1 – Response and aim of the objectives.
BACKGROUND
On 21 July 2017, samples taken from 
a dairy herd in the South Canterbury 
region of New Zealand tested positive for 
Mycoplasma bovis (M. bovis), a bacterium 
which causes disease in cattle, is 
widespread internationally, and has never 
been identified before in New Zealand. By 
causing untreatable disease in cows, M. 
bovis can mean significant and ongoing 
losses to dairy and beef producers 
and have severe disease management 
and animal welfare implications. The 
outbreak was diagnosed in non-lactating 
cows. Clinical symptoms observed were 
predominantly mastitis involving multiple 
quarters with approximately 40% of 
animals within the cohort affected. In a 
limited number of cows, lameness with 
arthritic lesions localised in the fetlock 
was observed. Subsequently at the time 
of calving calf illness was observed with 
premature calves born. Affected calves 
showed limited ability to feed and these 
either died or were euthanized.
The investigation undertaken by the New 
Zealand Ministry for Primary Industries 
(MPI) confirmed the diagnosis of M. bovis 
by culture, PCR and DNA sequencing [1]. 
Previous industry surveillance undertaken 
in 2009 had demonstrated that the 
organism was considered to not be present 
in New Zealand. Based on this information 
and results from the initial investigation of 
the current outbreak, the decision was 
made to undertake a national response 
with the following objectives (Table 1.)
CURRENT SITUATION 
The response initially involved standard 
epidemiological procedures of 
identification of likely infected properties 
based on tracing followed by testing 
and confirmation of infection status. 
Additionally, surveillance using bulk and 
mastitic milk samples by PCR testing was 
undertaken for all dairy herds nationally 
during late 2017 and early 2018. This milk 
surveillance is being currently repeated 
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This map and all information accompanying it is intended to be used as a guide 
only, in conjunction with other data sources and methods, and should only 
be used for the purpose for which it was developed. The information 
shown in this Map is based on a summary of data obtained from various sources.
While all  reasonable measures have been taken to ensure the accuracy of the 
Map, MPI: (a) gives no warranty or representation in relation to the accuracy, 
completeness, reliability or fitness for purpose of the Map; and (b) accepts no liability 
whatsoever in relation to any loss, damage or other costs relating to any person’s use 
of the Map, including but not limited to any compilations, derivative works or 
modifications of the Map. Crown copyright ©. This map is subject to Crown copyright
administered by Ministry for Primary Industries.
0 230115 Km
Created by the Geospatial
Management Team
Number of active confirmed Infected Properties 37
Number of properties under Restricted Place Notice 58
Number of samples received by AHL 195,746
Number of tests completed 181,971
Number of traced properties 5,137
Table 2 – Response statistics to 26 September 2018.
with all dairy herds being testing during the 
Spring calving period, six tests repeated 
every two weeks using PCR and Elisa, to 
identify any herds not already detected. 
Testing of meat animals at slaughter 
premises is also being undertaken. 
The decision to continue to undertake 
eradication will be reviewed in late 2018 
based on the results of the current testing 
programme.
To date all properties that have been 
identified as infected have occurred as 
a result of animal movements occurring 
from the index property or properties 
subsequently infected as a consequence 
of purchase of infected stock from the 
index property. All evidence suggests a 
single point of entry of the disease which 
occurred in late 2015 – early 2016 (Table 
2). The pathway has not been established. 
All properties identified (Figure 1) as 
infected are being depopulated, subject 
to cleaning and disinfection and then 
repopulated. The activities that are 
being undertaken are using the powers 
of the Biosecurity Act. This includes 
compensation for losses incurred for 
affected farmers.
CONCLUSION 
The eradication of M. bovis from the New 
Zealand cattle population will continue 
until there is either technical evidence 
that it is not feasible and/or there is not 
economic justification to support current 
controls. To date the spread of disease 
and the control measures adopted support 
continuation of the existing response.
Lindsay Burton
Fonterra Co-operative Group 
Ltd, New Zealand 
 lindsay.burton@fonterra.com
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With the aim of improving the competi-
tiveness of the dairy chain, the Ministry 
of Agroindustry of the Nation through 
the Direction of Dairy, has developed the 
Argentine Milk Quality Programme. The 
Programme is a public-private initiative, 
promoted by the Ministry of Agroindus-
try as part of a true State policy aimed at 
continuous improvement of milk quality. 
To do this, the first list of milk reference 
parameters was established, with the aim 
of establishing a criterion of comparability 
and valorising quality. 
The programme aims at training 
veterinarians. The following institutions 
participate in the programme: Ministry of 
Agroindustry, National Service of Health 
and Agro-Food Quality (SENASA), National 
Institute of Agricultural Technology (INTA), 
National Institute of Industrial Technology 
(INTI) and Pro Quality Milk Association 
and its derivatives (APROCAL).
The Argentine Milk Quality Programme 
is inspired by the vision of an Argentina 
Argentina: Training veterinarians 
through the Milk Quality Programme
”The Argentine Milk Quality 
Programme is inspired by the 
vision of an Argentina that 
has to project itself to the 
world and offers products 
of high quality from healthy 
animals. The actions of 
the Argentine Milk Quality 
Programme concern milk 
quality, disease control 
and animal welfare.”
Alejandro Sammartino
which has to project itself to the world 
and offers products of high quality from 
healthy animals (Figure 1). 
For the first time, the Reference Milk is 
established at national level: 
• Fat Content: 3.5 g / 100 cm3. 
• Protein content: 3.3 g / 100 cm3. 
• Somatic Cell Count: less than or 
equal to 400,000 cells / cm3.
• Total Bacteria Count: less than or equal 
to 100,000 colony forming units / cm3.
• Brucellosis: officially free.
• Tuberculosis: officially free.
• Cryoscopic index: less than - 0.512 ºC.
• Temperature in dairy farm: 
less than or equal to 4 ºC.
• Residues of inhibitors: negative.
Mastitis is one of the most prevalent 
and costly diseases affecting dairy cows 
worldwide. In addition, mastitis is one of 
the major animal welfare and economic 
problems in dairy cattle production. The 
losses due to mastitis are not just about 
economics: issues like animal health and 
welfare, quality of milk, antibiotic usage 
and the image of the dairy sector are also 
important reasons to focus on a mastitis 
control programme. Hence, the actions 
of the Argentine Milk Quality Programme 
concerning milk quality, disease control 
and animal welfare.
The programme aims at the accreditation 
of veterinary professionals in:
• Implementation of milk quality plans
• Milking machines
• Animal welfare and milking routines
• Economic losses due to 
milk quality problems
• Antibiotic treatment protocols
• Plans for prevention and 
control of mastitis
The Programme can be used as training 
for dairy farmers and milkers in:
• Good management practices
• Economic losses through re-
duction in milk quality 
• Records and information management
• Animal welfare
This training programme will take place 
during the second half of 2018 in Ataliva, 
Santa Fe, Argentina.
Agr. Alejandro Sammartino
Dirección Nacional Láctea, Argentina
 asammartino@magyp.gob.ar
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The World Organisation for Animal 
Health (OIE) and the Annual Collection 
of Data on the Use of Antimicrobial 
Agents in Animals
The OIE is an intergovernmental organi-
sation with a mandate from its 180 Member 
Countries to preserve animal health and 
animal welfare worldwide. Within its 
mandate, the OIE has developed standards 
and guidelines for animal health, including 
those on the responsible and prudent 
use of antimicrobial agents in veterinary 
medicine, and on monitoring antimicrobial 
resistance and antimicrobial use in animals.
Combatting antimicrobial resistance is a 
priority issue for the OIE, recognizing the 
vital role played by antimicrobials in human 
health, animal health and animal welfare. In 
order to ensure sustainability of livestock 
production, the efficacy of antimicrobials 
must be preserved through the principles 
of responsible and prudent use, and 
monitoring use allows countries to follow 
trends in its implementation.
Following Resolution No. 26: Combating 
Antimicrobial Resistance and Promoting 
the Prudent Use of Antimicrobial Agents 
in Animals, adopted by the OIE World 
Assembly during the 83rd General Session 
in May 2015 [1], the OIE launched an 
annual collection of data on the use of 
antimicrobial agents in animals. The first 
phase of this new OIE activity is also in line 
with the Global Action Plan on AMR, and 
with the recently published OIE Strategy on 
Antimicrobial Resistance and the Prudent 
Use of Antimicrobials [2]. 
FIRST PHASE OF OIE DATA COLLECTION
The template used to collect data was 
designed to allow all OIE Member Countries 
to participate, regardless of whether or not 
INTERNATIONAL 
PROJECT OUTCOMES
a national data collection system exists in 
their countries. The OIE template includes 
administrative information and provides 
three options for reporting antimicrobial 
usage in animals, with various levels of 
detail depending on the data available at 
the national level. 
In the first phase, 130 Member Countries 
(72% of the 180 OIE Member Countries) 
participated. A total of 89 of 130 OIE 
Member Countries (68%) submitted data 
specifying quantities of antimicrobial agents 
used in their animals for years ranging from 
2010 to 2015. 
The first report, OIE Annual report on the use 
of antimicrobial agents in animals: Better 
understanding of the global situation, can 
be found on the OIE Website [3] in English, 
French and Spanish. This report presents 
the findings of the first annual collection 
of data on the use of antimicrobial agents 
in animals, providing a global and regional 
analysis based on data ranging from 2010 
to 2015.
SECOND PHASE OF OIE DATA 
COLLECTION
For the second phase, participation has 
increased with 144 responses: 141 from OIE 
Member Countries (78% of 180 Member 
Countries) and 3 from non-OIE Member 
Countries. Moreover, more Member 
Countries are now able to report specifically 
on the classes of antimicrobial agents used 
in their animals from 2013 to 2016 (102 or 
72% of 141 Member Countries).
For this second phase, the OIE has also 
included a question on the obstacles coun-
tries face in order to provide quantities of 
antimicrobial agents in animals. When the 
analysis of this phase is complete, this sec-
tion will inform the needs of OIE Member 
Countries to collect antimicrobial use data.
OIE REGION
Number Member 
Countries who 
submitted 
templates by OIE 
Region
Number of OIE 
Member 
Countries by OIE 
Region
Proportion of 
Proportion of 
responses by OIE 
Region by OIE 
Region
AFRICA 44 54 81%
AMERICAS 19 29 66%
ASIA 26 32 81%
EUROPE 36 53 68%
MIDDLE EAST 5 12 42%
Table 1 – OIE Member Countries that submitted templates in 2015, by OIE Region.
“Combatting antimicrobial 
resistance is a priority issue 
for the OIE, recognizing 
the vital role played by 
antimicrobials in human 
health, animal health 
and animal welfare.”
Elisabeth Erlacher-Vindel
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WORK TO DEFINE A DENOMINATOR 
(ANIMAL BIOMASS)
Data collected to this point have been 
measured by amounts of different 
antimicrobial agents used in animals by 
country (in kg). To provide a more detailed 
interpretation, it is necessary to analyse the 
weight of antimicrobial agents consumed 
relative to the number of animals consuming 
them. Towards this goal, concurrent to the 
second phase of data collection, the OIE is 
developing calculations for animal biomass 
in its regions to use as a denominator in its 
analysis of the antibiotic usage database. 
This denominator will also facilitate a 
deeper understanding of use of antibiotics 
in animals, including trends in use over 
time, and comparisons of consumption 
patterns between regions and countries.
In order to determine animal biomass, the 
OIE will use a variety of sources, including 
published databases, literature review, and 
the OIE World Animal Health Information 
System (WAHIS), which collects census 
data on animal populations of Member 
Countries. Further work will be conducted 
to develop WAHIS in order to quantify 
the most accurate possible denominator 
over the long-term. Simultaneously, it 
is expected that Member Countries will 
improve the quality of their data on their use 
of antimicrobial agents in animals and allow 
refinement of the analysis over time.
E. Erlacher-Vindel1, M. Raicek2, D. 
Góchez2 • 1. Head of the Science and 
New Technologies Department, 2. Chargée 
de mission at the Science and New 
Technologies Department, International 
Organisation for Animal Health  
1.  e.erlacher-vindel@oie.int
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One Welfare – a complement to One 
Health supporting a sustainable dairy 
industry approach
‘One World, One Health’ was developed as 
a concept to achieve fully comprehensive 
approaches in support of global sustainable 
development. A set of principles (i.e., 
The Manhattan principles) were agreed 
following an event in 2004 organised by the 
Wildlife Conservation Society and hosted 
by The Rockefeller University. The concept 
of ‘One Welfare’ complements these by 
emphasizing the interconnections between 
animal welfare, human wellbeing and the 
environment. Integrating ‘One Welfare’ with 
‘One World, One Health’ helps strengthen 
and better integrate stakeholder liaison 
by capturing all relevant issues involving 
animals and our society in a holistic way 
[1].
ONE WELFARE FOR ALL
To date there has been a lot of progress 
towards developing and implementing the 
concept of One Health in relation to how 
animal disease interconnects with human 
disease and productivity, among other 
aspects. However, the interconnections 
go beyond health and extend to wellbeing, 
environmental and conservation aspects. 
These are captured more explicitly by the 
concept of One Welfare. “One Welfare” 
describes the interrelationships between 
animal welfare, human wellbeing and 
the physical and social environment [3]. 
Recognising the links between animal 
welfare, human wellbeing and the 
environment represents a step forward 
in the implementation of animal welfare 
standards and policies, with the aim of 
integrating animal welfare with other 
relevant areas for the benefit of all [2]. This 
concept has the goal to help improve global 
welfare and achieve gains in development.
Health and welfare are inextricably linked 
within dairy cattle and partially overlap 
when we talk about their ‘quality of life’. 
‘Health’ most often refers to the state of 
being free from disease, while the terms 
‘welfare’ and ‘wellbeing’ more often relate 
to mental and emotional states. Generally, 
you cannot have positive welfare without 
good health. In a similar way, good welfare 
will support and be connected to good 
health [3]. Evidence shows that improved 
animal welfare leads to herds with stronger 
immune systems, less prone to disease 
and, as a result, less likely to need 
antimicrobials.
The Dairy Sector is subject to production 
pressures, relying heavily, not only on 
management and farm resources, but 
also on natural resources such as land 
availability, water availability, feed quality or 
climate conditions (i.e., dry/wet seasons), 
all of which are interconnected with human 
society and our planet. This makes the 
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concept of One Welfare very relevant 
to the current farming and dairy herd 
management approach.
Life Cycle Assessment that evaluate 
carbon or water footprints are key to 
measuring natural resource impacts which 
we can then correlate to other parameters 
such as animal welfare improvements. 
These allows us to better understand how 
animal welfare improvements, both animal 
and resource based, as well as changes at 
management level, can impact the wider 
environmental issues. There is a holistic 
interconnection between the welfare of 
the animals, humans and the environment, 
thus we can apply a One Welfare Approach 
and aim to maximize benefits for all.
The role of the dairy sector in society by 
using a One Health, One Welfare approach 
is consistent with the United Nations 
Sustainable Development Goals in animal-
related areas by helping to ‘build economic 
growth and address a range of social 
needs including education, health, social 
protection and job opportunities, while 
tackling climate change and environmental 
protection’ [4].
THE ONE WELFARE FRAMEWORK
The One Welfare Framework includes five 
key sections that capture the overarching 
themes of One Welfare including: the 
Connections Between Animal and 
Human Abuse and Neglect; the Social 
Implications of Improved Animal Welfare; 
the connection between Animal Health and 
Welfare; Human Wellbeing; Food Security 
and Sustainability within the farming 
sector; Assisted interventions Involving 
Animals, Humans and the Environment and 
the more holistic aspect of Sustainability, 
including the interconnections between 
biodiversity, the environment, Animal 
Welfare and Human Wellbeing [3].
Each section is linked to the dairy sector. 
For instance, the interconnection between 
dairy cattle welfare and productivity; 
between farmer wellbeing and herd welfare 
or natural resource; the impact of conflict 
or environmental disasters on dairy farmers 
and their herd or the use of sustainable 
management through silvopastoral 
systems in dairy farming.
By expanding One Health into One Welfare, 
the dairy sector can make more explicit the 
recognition between the interconnections 
of animal welfare, human wellbeing and 
the environment. This is a step forward 
in the implementation of animal welfare 
standards and policies, with the aim of 
integrating animal welfare with other 
relevant areas for the benefit of all, and the 
overarching society.
For further information on One Welfare see: 
www.onewelfareworld.org.
Dr. R. García Pinillos 
Director, One Welfare Community Interest 
Company  
 onewelfare@outlook.com
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”Recognising the links 
between animal welfare, 
human wellbeing and the 
environment represents 
a step forward in the 
implementation of animal 
welfare standards and 
policies, with the aim of 
integrating animal welfare 
with other relevant areas 
for the benefit of all. One 
Welfare describes these 
interrelationships”  
Rebeca García Pinillos
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Animal health and welfare: Results of the IDF questionnaire 
Data obtained between 2014 and 2016
AIM OF IDF WORK
The results presented are from a 
questionnaire sent to all members of 
the International Dairy Federation (IDF) 
Standing Committee on Animal Health 
and Welfare (SCAHW) in 2014. The goal of 
the questionnaire was to map the health 
status and other items of interest on 
animal welfare in different countries. The 
specific aims were: 1) to identify the most 
important diseases for dairy farmers; 2) to 
identify the most important diseases for 
dairy processors; 3) to identify the most 
important issues on animal welfare; and 
4) to map the feature of ongoing mastitis 
control in different countries.
The questionnaire was not focused on 
OIE-listed diseases, but on everyday 
production and infectious diseases with 
an economic or quality impact on the dairy 
industry.
The final purpose of this project is to 
help the SCAHW members determine 
the priority topics for the programme of 
SCAHW’s work. Seventeen countries 
responded to the questionnaire. Some 
of the questions were not possible to be 
answered because of the lack of national 
data. The following countries responded: 
Belgium, Canada, Chile, Denmark, Finland, 
France, Germany, Iceland, Ireland, Italy 
(Lombardia), the Netherlands, Norway, 
South Africa, Switzerland, Sweden and 
the UK.
THE MOST IMPORTANT DISEASES 
The countries were asked to name the 
top five most important diseases for dairy 
farmers. Mastitis was listed as one of 
the most important in 16 countries and 
as the most important in nine countries. 
Reproduction was mentioned by 12 
countries and as the most important area 
of disease in three countries. Table 1 
illustrates all diseases listed.
RESEARCH
ANIMAL WELFARE
Countries were asked about the current 
and future issues for animal welfare in the 
country. The results are shown in Table 3.
DAIRY CATTLE POPULATIONS
The structure of the dairy population is 
very diverse and has an impact on the 
management and on health parameters. 
The number of farms in the countries 
surveyed varied from 600 to 76,000. 
However, most countries had from 1,000 
to 20,000 farms. The number of cows 
within the country ranged from 30,000 to 
4.3 million, most having between 230,000 
and 650,000 animal heads.
Diseases of importance for 
dairy farmers
Number of countries 
where the disease 
was listed as the 
most important
Number of countries 
where the disease was 
listed as one of the top 
five most important 
diseases
Mastitis 9 16
Reproduction 3 13
Lameness 1 11
Bovine tuberculosis 1 2
Bovine ephemeral fever (BEF) 1 1
Bovine herpes virus (HV-1) 1 0
Bovine virus diarrhoea (BVD) 0 8
Calf diseases 0 5
Ketosis 0 2
Stillborn 0 2
Insect transmitted diseases 0 2
Metabolic diseases 0 2
Bovine digital dermatitis (BDD) 0 1
Tick-borne diseases 0 1
Johne’s disease 0 1
Milk fever 0 1
Bovine leucosis virus (BLV) 0 1
Infectious diseases 0 1
Table 1 – Diseases of importance for dairy farmers listed on the IDF questionnaire.
”Most countries reported 
a large reduction in rate of 
clinical mastitis over the last 
ten years. There has been a 
large improvement in udder 
health, with the largest 
reduction in clinical mastitis.”  
Olav Østerås
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Disease of importance for 
dairy processors
Number of countries 
where the disease 
was listed as the 
most important
Number of countries 
where the disease was 
listed as one of the top 
five most important 
diseases
Mastitis 6 9
Johne’s disease 2 8
Salmonellosis 1 3
Campylobacter 1 0
Arbovirus 1 0
Bovine tuberculosis 1 0
Infertility 1 0
Claw diseases/Lameness 0 4
E. coli (EHEC) 0 2
Metabolic diseases 0 2
Listeriosis 0 1
Lumpy skin disease 0 1
Foot and mouth disease (FMD) 0 1
Tick borne diseases 0 1
Bovine virus diarrhoea (BVD) 1
Bovine respiratory syncytial virus 
(BRSV)
0 1
Blue tongue 0 1
Insect transmitted viruses 0 1
Infectious diseases leading to 
antibiotic usage
0 1
Calf disease 0 1
Table 2 – Diseases of importance for dairy processors listed on the IDF questionnaire.
Results originate from the existing animal 
recording system data at national level. 
Thus, the data presented is limited by the 
existence of animal recording programmes 
in the countries surveyed. The number of 
herds included in the recording systems 
usually varied between 20% and 95% 
of herds, although in most countries this 
included 80% to 90% of the herds. The 
number of cows included varied from 
12% to 95% whilst most programmes had 
between 80% and 90% of cows.
Herd size mean varied between 25 
and 350 cows, being in most countries 
between 40 and 100. The percentage of 
cows in first lactation varied from 16% to 
45%, with most herds having around 35% 
to 38%. A closer look to the distribution of 
herd size shows clusters from 20 to 500 
animals in most countries. There were 
only a few herds above 500 and below 20 
(Figure 1).
The proportion of herds having cows in 
free-stalls or cubicles varied between 
35% and 100%. In some countries, this 
distribution varied from 35% to 40% while 
in others from 60% to 90%.
The proportion of herds using automatic 
milking systems (AMS) varied from 3% to 
23% and many had around 20%.
The milk yield per cow varied from 5,100 to 
12,041 kg. In most countries this ratio was 
between 8,000 and 10,000 kg (Figure 2).
UDDER HEALTH
Udder health can be expressed in different 
ways. One is the mean somatic cell counts 
(SCC) in bulk milk. The recommended 
figure is the geometric mean as the 
distribution is generally skewed to the right 
and the arithmetic mean will, therefore, be 
higher. The geometric mean varied from 
106,000 to 218,000. The arithmetic mean 
varied from 131,000 to 257,000. Most 
countries had a geometric mean around 
200,000 (Figure 3).
CLINICAL AND SUBCLINICAL MASTITIS
Eight countries have a national register 
on treatment rate of clinical mastitis. The 
estimated rate of cases per one hundred 
cows per year varied from 8.1 to 48. Most 
countries had around 30. Subclinical 
mastitis is estimated as a proportion of 
“This questionnaire covered 
17 countries with a total 
of 279,000 herds and 18 
million cows.The outcomes 
presented in this document 
might help the IDF SCAHW 
to prioritize the work needed 
to improve animal health and 
welfare in the dairy sector.”  
Olav Østerås
Issue
Number of 
countries that 
listed this issue
Pasture 8
Lameness and 
injuries
7
Housing (tie-stalls, 
slatted floors)
5
Separation mother 
– calf 5
Pain control during 
dehorning
4
Mastitis 3
Dead cows 1
Cow comfort 1
Bull calf export 1
Education of 
farmers 1
Welfare and quality 
in AMS 1
Heat stress 1
Breeding goals 1
Slaughtering 
pregnant cows
1
Table 3 – Diseases of importance for dairy farmers 
listed on the IDF questionnaire.
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milk analyses at cow level with 200,000 somatic cell counts or 
above. Only six countries gave figures on subclinical mastitis. 
These figures varied from 19.4% to 40%. Most countries have 
figures from 20% to 25%. 
The frequency of dry-cow therapy was given from five countries. 
These figures vary from 4.9% to 64.8%. The rate variation on 
clinical mastitis, subclinical mastitis and dry-cow therapy is 
given in Figure 4.
There was a striking difference between countries. Scientific 
literature illustrates a large difference from 25–28 cases per cow 
and years in the Netherlands (Barkema et al. 1998). Schukken 
et al. (1989) found ten herds with low SCC with a rate of clinical 
mastitis of 2.2 cases per 100 cows, while ten other herds with 
the same low SCC had a clinical mastitis rate of 53.6 cases per 
100 cows. In New Zealand, 19 cases per 100 cows - 305 days in 
milk were reported (Petrovski et al. 2009). This illustrates a huge 
variation between farms and between countries.
Figure 5 illustrates the distribution of clinical mastitis rate and 
geometric mean SCC between herds in Norway as well as the 
lack of correlation between clinical mastitis rate and bulk milk 
somatic cell count (BMSCC).
Most countries reported a large reduction in rate of clinical 
mastitis over the last ten years. The reduction varied from 
5.4% to 61%. There was also a reduction in BMSCC in most 
countries, but a few countries had an increase in BMSCC. Three 
countries reported an increase in BMSCC (5.5–7.8%) and four 
countries reported a decrease (3%–40%) (Figure 6). The figure 
illustrates a large improvement in udder health over the last ten 
years, with the largest reduction in clinical mastitis. This is a 
good trend as there is a goal to reduce and improve the prudent 
use of antibiotics. It also illustrates that this reduction can be 
done without detrimental effect on BMSCC.
Eight countries gave feedback on the distribution of different 
bacteria as cases of mastitis both clinical (Figure 7) and 
subclinical (Figure 8). The most frequent agents in clinical mastitis 
are Staphylococcus aureus, Escherichia coli, Streptococcus 
uberis, Streptococcus dysgalactiae and coagulase negative 
staphylococci (CNS). For subclinical mastitis CNS was the most 
prevalent, followed by S. aureus, Corynebacterium bovis.
Sensitivity to penicillin for S. aureus was given by five countries. 
The percentage of sensitive isolates varied from 86.3% to 
98.8% for clinical mastitis and 96% to 98.6% for subclinical 
mastitis. The conclusion was that most of the S. aureus isolates 
are sensitive to penicillin in those countries with available data.
Concerning coagulase-negative staphylococci (CNS), a 
much lower percentage of sensitive isolates to penicillin were 
reported. Isolates from clinical mastitis varied from 57% to 91% 
and isolates from subclinical mastitis around 65%. Scientific 
research demonstrated that there is a huge difference between 
different species of CNS.
Figure 1 – The distribution of herd sizes in different countries.
Figure 2 – Mean milk yield in kg per cow and year.
Figure 3 – Distribution of geometric mean and arithmetic mean in 
bulk milk somatic cell count in different countries.
Figure 4 – Rate of clinical mastitis (cases per 100 cows), subclinical 
mastitis (percentage per analyses) and dry-cow therapy per 100 
cows reported in the questionnaire.
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BACTERIAL COUNTS
Bacterial count in milk was very difficult to measure because 
different units are used: some countries reported on colony 
forming units (cfu) while others used bactocount (bc). In addition 
to this, many countries used a different converting factor between 
cfu and bc. The reported cfu values varied from 5,500 to 30,000 
and the bc reported values varied from 8,100 to 28,000. These 
figures must be taken as a weak indication on levels.
SAMPLING PROCEDURE
Quality sampling from each delivery was done in four countries, 
weekly sampling in five countries and twice a month sampling in 
three countries.
The frequency of obtaining data from the animal recording 
system at animal level varied between countries. It was done five 
times a week in one country, once a month in three countries, on 
a voluntary basis in one country, four times a year in one country, 
seven times a year in two countries and five to 10–12 times a 
year in another three countries.
QUALITY LIMITS 
The quality limits given for BMSCC was for premium quality: < 
100,000 (one country), < 200,000 (three countries), < 230,000 
(one country), < 250,000 (one country) < 300,000 (one country) 
and < 500,000 (one country). Additional price was given as an 
increase in milk price from 0.64 to 10%.
First class milk was given limits of > 150,000 (one country), > 
300,000 (four countries), > 350,000 (two countries) and > 400,000 
(one country). The percentage adjusted price varied between 2 
and 8 percent.
Second class milk was given limits of > 300,000 (one country), 
380,000 (two countries), > 400,000 (one country) and > 500,000 
(one country). Withdrawal in price was from 2 to 7 percent.
Third class milk was given limits of > 350,000 (one country), > 
400,000 (one country), > 500,000 (one country) and > 800,000 
(one country). Adjusting of the price was between 7 to 14 percent.
The stop limit was set at 400,000 for eight of the countries. This 
is the general limit for EU.
RECOMMENDED PREVENTIVE PROCEDURES
Post-milking teat dipping
Thirteen countries recommended post-milking teat dipping 
regularly, eleven for all herds and two for selected herds (those 
with a streptococcal problem).
Pre-milking teat dipping
Of eleven countries, eight recommended regular pre-milking teat 
dipping, two for all herds, eight for selected herds, one did not 
recommend pre-milking teat dipping and one had it forbidden. 
The criteria recommended where there was selective use of pre-
milk dipping, were for environmental mastitis, poor teat hygiene 
or ‘severe’ outbreaks of S. aureus or salt-tolerant spores.
Figure 5 – The distribution of clinical mastitis, BMSCC and 
correlation between clinical mastitis and BMSCC.
Figure 6 – Percent reduction of clinical mastitis and bulk milk 
somatic cell count (BMSCC).
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Dry-cow therapy
All eleven countries recommended 
some kind of dry-cow therapy. Three 
recommended total dry-cow therapy for 
all cows, ten only recommended it for 
selected herds, and eleven recommended 
dry-cow therapy for selected cows.
The selected criteria stated in different 
countries are given here:
• Cows with SCC > 150,000 or 100,000 
for heifer and older cows respectively
• > 150,000 in BMSCC and cows  
> 100,000 and culture positive
• Proven infected
• Primiparous > 150,000 and 
multiparous > 50,000
• > 100,000 in geometric means DHI 
2 or 3 samples and culture positive 
with S. aureus or Streptococcus spp. 
• Eradication of Str. agalactiae
• SCC > 200,000 and previous CM
• SCC and infection status
• Includes herd mastitis history, bac-
teriology results, individual cow 
SCC and clinical mastitis records
The results suggest that selective dry-
cow therapy is now implemented in most 
countries instead of total dry-cow therapy. 
There has been a shift over the last five 
years. This is also in accordance with IDF 
guidelines on antimicrobial agents (AA) 
use (only to be used to cure infections) 
(IDF, 2013 and 2017).
Teat sealant
Seven out of ten countries recommended 
teat sealant, three recommended teat 
sealant for all herds, six countries 
recommended teat sealant for selected 
herds and eight only for selected cows.
• The selection criteria were:
• Environmental bacteria
• Crowded deep bedding
• No high SCC last control
• Leaking cows
• Includes decisions made on dry-
cow therapy, operator technique, 
herd mastitis history, bacteriol-
ogy results, individual cow SCC 
and clinical mastitis records
Environment
• For housing, the recommendation 
was: ventilated, clean, dry areas, 
spacious, free-stalls and cow comfort.
• For milking machines: yearly check-
up, regular control, control during 
milking (VADIA) and control every 
year by a certified specialist.
• For milking methods: Audit during 
milking every 3rd year, preparation time 
60 to 120 seconds, take off at 400 ml/
minute when two times milking a day, 
and 600 ml/minute when milking three 
times a day, udder preparation, dry, 
clean teats, milking gloves, wet and dry 
preparation, careful attachment, check 
if udder is empty and careful removal.
• For feeding: Check-up regularly, bunk 
space, total mixed ration always 
available, avoid fat cows, not extreme 
production at start of lactation, in one 
country (Switzerland) 40% of dairy 
farms are not allowed to feed on silage.
Drug recommendation
The recommendations for the use of drugs 
from different countries were:
• Responsible use (not defined).
• Use drugs only if justified.
• Maximum six daily doses per ani-
mal per year, 3rd and 4th generation 
cephalosporines only in exceptions.
• Penicillin G only, sometimes sul-
famides. Avoid broad-spectrum 
antibiotics to prevent AMR.
• Treatment of antibiotics or hor-
mones only under veterinarian 
supervision. Performance en-
hancing drugs are forbidden.
SUMMARY AND CONCLUSIONS
This questionnaire covered 17 countries with 
a total of 279,000 herds and 18 million cows. 
This study would benefit from additional 
responses, in particular from countries with 
high dairy production. Yet, the results give 
an idea of the situation in the dairy sector. 
The intention is to redo this questionnaire 
and update it regularly; preferably before 
the regular IDF mastitis conference (the 
next one will be in Denmark in May 2019). 
The dairy structure is very diverse, and 
this will have an impact on the results for 
each country. The disease strategy might 
have to be adapted to each country. Also, 
the production and the quality payment 
system are diverse. Only five countries 
seem to have regular recording of disease 
(mastitis) treatment (Nordic countries and 
Israel). Some countries have some good 
information through good surveys on 
clinical mastitis. However, most countries 
do not seem to have any information of 
the situation. The same can be said for 
bacteriological isolates from mastitis.
A dramatic reduction in the treatment rate of 
clinical mastitis can be seen over the last ten 
years (reduction varied from 10% to 60%); yet 
BMSCC do not seem to be influenced by the 
reduction of clinical mastitis cases. Results 
on BMSCC show both an 8% increase and a 
40% reduction at the same time.
Most countries have abandoned the total 
dry-cow therapy as a strategy and are on 
the way to implementing selective dry-cow 
therapy. There is a large discrepancy in 
the selection criteria used. No association 
between BMSCC, rate of clinical mastitis 
or rate of dry-cow therapy results was seen 
between countries. A few countries had 
already implemented a stringent and specific 
recommendation on drug usage, and most 
were implementing prudent use of AA.
Rank 1
(15-30% 
pathogens)
Rank 2
(11-24% 
pathogens)
Rank 3
(9-18% 
pathogens)
Rank 4
(2-15% pathogens)
Rank 5
(2-15% 
pathogens)
S. aureus (5) E. coli (3) S. dysgal (3) CNS (3) S. dysgal (4)
E. coli (3) S. uberis (2) S. agalac (1) S. uberis (2) S. uberis (1)
S. dysgal (1) CNS (1) Enterococ/E. coli (2) M. bovis (1)
CNS (1) S. aureus (1) S. aureus (1) Prototeca (1)
S. aureus (1) S. uberis 
Figure 7 – Bacterial isolates from clinical mastitis grouped according to percentage of isolates. Number in 
brackets is number of countries given.
Rank 1
(5-70% 
pathogens)
Rank 2
(3-25% 
pathogens)
Rank 3
(9-18% 
pathogens)
Rank 4
(4-14% pathogens)
Rank 5
(0.4-5% 
pathogens)
CNS (4) S. aureus (3) S. dysgal (3) S. dysgal (3) S. dysgal (1)
S. aureus (2) CNS (1) S. uberis (3) S. aureus (2) S. agalac (1)
S. bovis (1) S. bovis (1) CNS (1) S. uberis (1)
S. uberis (1) Cor. spp (1)
Figure 8 – Bacterial isolates from subclinical mastitis grouped according to percentage of isolates. 
Number in brackets is number of countries given.
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The most prevalent bacteria in clinical 
mastitis were S. aureus, E. coli, Str. uberis 
and Str. dysgalactiae. The most prevalent 
bacteria on subclinical mastitis were CNS, 
S. aureus, Corynebacteriae spp., Str. uberis 
and Str. dysgalactiae. Most S. aureus were 
sensitive to penicillin. However, about 40% 
to 60% of CNS were not.
The questionnaire illustrated huge progress 
on udder health, at least in the countries 
that responded. The pressure to reduce the 
use of antibiotics is expected to increase. 
This questionnaire demonstrates that the 
use of antibiotics in the 1980s and 1990s 
was unnecessary in many countries, since 
antibiotic usage reduction has not led to an 
increase in BMSCC. 
Reproduction, lameness, bovine 
tuberculosis, calf diseases and different 
virus diseases like bovine herpes virus 
and BVD remain important in many 
countries. The relative importance was 
slightly different for dairy farmers than for 
dairy processors. Dairy processors found 
mastitis the most important disease, 
followed by Johne’s disease, salmonella, 
campylobacter, EHEC and listeria. On 
animal welfare, pasture, lameness, 
housing, separation mother-calf bovine 
tuberculosis, pain control by dehorning 
and mastitis were found to be important.
The outcomes presented in this document 
will help the IDF SCAHW to prioritize the 
work needed to improve animal health 
and welfare in the dairy sector. 
O. Østerås, DVM, PhD
TINE Norwegian Dairy, Norway
 olav.osteras@tine.no
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Rethinking definitions for mastitis 
detection: Leaving the paradigm of 
only clinical mastitis
IDF ACTION TEAM ON GUIDELINES ON 
THE USE OF SENSORS FOR ANIMAL 
HEALTH AND PRODUCTIVITY
Dairy Farmers worldwide have available 
several sensor systems, particularly to 
measure cow health and fertility. The 
work on sensors can be immensely broad 
since there is a wide range of animal 
health and fertility problems that could 
be addressed by using sensor systems. 
None of the systems currently available 
provides reliable automated decision 
support (Rutten, 2013). The IDF action 
team has decided to work on standards 
for the evaluation of sensor systems aimed 
at those areas of management (existing or 
novel) which support interventions by the 
dairy farmer. 
Since the early 1990s, research has been 
carried out on automated detection of 
mastitis (Brandt et al. 2010; Nielen et al. 
1992). Mastitis is associated with two 
aspects of milk quality which are used in 
most dairy producing countries: somatic 
cell count (SCC) and, if mastitis is clinical, 
visibly abnormal milk (in the remaining part 
of this article referred to as abnormal milk). 
Moreover, mastitis is the most prominent 
production disease in developed dairy 
producing countries. The development and 
use of on-line mastitis detection systems 
has received much attention following the 
introduction of automatic milking systems 
(AMS) in the mid-1990s (Viguier et al. 2009). 
On dairy farms working without an AMS, a 
well-established method to detect clinical 
mastitis (CM) is to strip before milking and 
check the foremilk for abnormalities. During 
milking, abnormal milk was detected using 
visual observations.
Since 1992, approximately 20 peer-
reviewed papers have been published with a 
description and evaluation of CM detection 
models (Hogeveen et al. 2010). There is a 
large variation in the use of sensors and 
algorithms. All this makes these results 
incomparable. There is also a considerable 
difference in performance between the 
detection models, and a broad variation 
in time window used and little similarity 
between study data. Therefore, it is difficult 
to compare the overall performance of the 
different CM detection models. Thus, dairy 
farmers could make misguided investment 
decisions. 
Until now, research on automated mastitis 
detection systems has been using 
methods from the visual mastitis detection 
era as the gold standard. For decades, on-
farm clinical mastitis detection was based 
on a visual observation of milk, a clinical 
examination of the udder and the general 
condition of the cow and supported 
by semi-quantitative measurement of 
somatic cell counts, e.g., by CMT testing. 
Although the test accuracy of automated 
CM detection systems might be lower 
than trained clinicians of milking staff, 
repeated sampling at each milking has the 
ability to identify subclinical changes and 
monitor them over time for early detection 
of intramammary infections. Sensors for 
the automatic detection of abnormal milk 
defined as colour changes, deviating 
electrical conductivity or changes in other 
inflammatory markers are increasingly 
implemented in automated milking systems 
as well as in milking parlours, although 
they either do not meet the standards for 
”The IDF action team 
has decided to work on 
standards for the evaluation 
of sensor systems aimed at 
those areas of management 
(existing or novel) which 
support interventions 
by the dairy farmer.” 
Henk Hogeveen 
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test accuracy set years ago or their test 
performance is unknown [5]. 
The IDF has a leading voice on mastitis 
in the dairy industry. Therefore, guidance 
on the evaluation of test performance 
and use of data originating from sensors 
for udder health management should 
derive from the IDF. In consequence, an 
IDF action team is currently working on 
guidelines encompassing exactly what 
types of intramammary infections, clinical 
and subclinical, a sensor system should be 
able to detect, with a focus on the potential 
interventions by the farmer rather than on 
the old paradigms. 
The IDF Action Team on sensors is working 
on the following areas based upon the 
potential interventions by the farmer: 
• Cows needing immediate attention. 
• Cows not needing immediate atten-
tion: subclinical signs and others. 
• Cows needing attention at drying off.
• Udder herd health monitoring 
and management based on crit-
ical control points from herd 
specific sensor technology.
This work will be presented at the IDF 
Mastitis Conference 2019 in Copenhagen.
H. Hogeveen1, G. Dalen2, Ilka Klaas3
1Wageningen University, the Netherlands
2TINE Norwegian Dairy, Norway 
3DeLaval International AB, Sweden
 henk.hogeveen@wur.nl
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CONCLUSIONS
The results presented during the 2018 
International Bovine Mastitis Conference 
contribute to a better understanding of 
the onset of inflammation of the mammary 
gland of dairy cows. Improvement of 
immunity responses and adequate 
herd management are crucial to control 
mastitis in the absence of preventive 
antimicrobials.
DIMINISH MASTITIS TO LIMIT 
ANTIMICROBIAL USE 
Livestock has been recognized as a main 
source of bacterial pathogens displaying 
antimicrobial resistance. This is likely 
due to the considerable amounts of 
antimicrobials used in this sector per kg of 
live biomass. There is concern that either 
pathogens or genetic materials coding for 
antimicrobial resistance could move from 
animals to humans. Incidents of humans 
being infected by methicillin-resistant 
Staphylococcus aureus and, especially, 
extended-spectrum beta-lactamase 
(ESBL) Escherichia coli originating from 
animals have led to plenty of media 
exposure. 
In dairy herds, however, these arguments 
are less applicable because resistance 
levels are generally low, transmission of 
resistance genes to humans is assumed to 
be of minor importance, and all milk being 
delivered to dairy processor is tested for 
antimicrobial residues. Moreover, more 
recent studies based on precise sequence-
based population level data indicate that 
little or no host transfer of ESBL genes 
of bacteria takes place between animal 
species or between animals and humans 
[1].
Up to 85% of antimicrobials used in the 
dairy sector aim at mastitis control [2]. 
Mastitis is the expression of a serious 
inflammatory response resulting from a 
dysfunction of the innate immune system, 
involving a combination of enhanced 
production of proinflammatory molecules 
and reduced levels of anti-inflammatory 
ones. This usually occurs in periparturient 
cows, due to the fact that the immune 
system is suboptimal at time of calving. 
The innate immune system of a cow’s 
udder can mount a response to both 
infectious and non-infectious stressors. 
The elimination of an antibiotic shield does 
not necessarily have to result in a higher 
rate of new intramammary infections. By 
modifying the known risk factors and by 
optimising herd management, risk levels 
can be equally low as when prophylactic 
antimicrobials are used.
CONTROL OF INFECTIOUS STRESSORS 
Infectious stressors are constituted by the 
different pathogens present in the udder, 
which might provoke relatively different 
inflammatory responses. For instance, 
S. aureus leads to an inadequate and 
somewhat weak inflammatory response 
because it incites a rather low bacterial 
recognition through toll-like receptors 
and a slower expression of inflammatory 
mediators. Because neutrophil functions 
are diminished, this pathogen evades 
mammary gland immune responses, 
leading to chronic subclinical disease. On 
the other hand, Gram-negative bacteria, 
such as E. coli, give rise to a more acute 
and exacerbated response due to delayed 
leukocyte response and rapid bacterial 
growth, resulting in increased endotoxin 
exposure [3].
Fostering the immune system for optimal 
responses can help cows resist the 
establishment of mastitis when infections 
occur. As a first option, one might try to 
control microbial pathogens by active 
immunization. Vaccines could include 
antibodies to bacterial toxins and/or 
bacterial secretion products (biofilms) 
which are able to reach adequate protective 
titers in the mammary gland. Proper 
protocols of immunization should not 
induce “dangerous” types of inflammatory 
response or cause tissue damage. To this 
end, adjuvants containing antibodies to 
Dry, clean and properly nourish 
cattle to diminish mastitis and limit 
antimicrobial use 
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mucosal addressin might sustain local, 
non-inflammatory IgA responses in the 
mammary gland. As a second option, 
induction of endotoxin tolerance in the 
mammary gland and innate immune 
memory could be exploited. This can be 
achieved by intracanalicular injections of 
low-dose bacterial pathogen-associated 
molecular patterns at dry-off [3].
Mastitis control is facilitated by early 
detection of cows and quarters which 
require attention. Specific and cost-
effective diagnostic sensors can be used. 
Clinical mastitis treatments must then be 
decided upon on-farm culture. Selective 
dry cow therapy is the way forward, 
with no prophylactic use at dry off. An 
alternative novel diagnostic approach for 
accurate mastitis pathogens identification 
is provided by 16S rRNA gene sequencing 
of the ‘milk microbiome’ [4]. Cause and 
effect relationships between mastitis and 
the “milk microbiome” are still a little far-
fetched and it is not fully clear yet whether 
the bacterial DNA found in milk represents 
a genuine and representative microbiome. 
CONTROL OF NON-INFECTIOUS 
STRESSORS 
Among non-infectious stressors, 
inappropriate nutrition can modulate the 
generation of inflammatory lipids [5]. After 
calving, imbalances in dietary nutrients or 
metabolic adaptations, such as a negative 
energy balance, can increase metabolic 
stressors, such as non-esterified 
fatty acids (NEFA) [3]. Interestingly, 
autochthonous cattle breeds have shown 
to possess better fundamental innate 
immune responses in the mammary gland 
and other crucial metabolic features [6]. 
For instance, high NEFA levels seem to be 
more likely to occur in high-yielding animal 
phenotypes, such as Friesian cows, when 
compared to, for instance, Brown Swiss 
cows [3]. Prevention of inflammatory 
lipids can be done by avoiding intense 
lipid mobilization after calving, optimizing 
inflammatory responses with diets rich 
in omega-3 fatty acids and appropriate 
micronutrient supplementation. Omega-3 
fatty acids are known to have anti-
inflammatory properties. Feeding cows 
with such omega-3 fatty acids, such as 
linseed or fish oil, improves lymphocyte 
function during negative energy balance, 
enhances immunity during high-ambient 
temperatures and improves milk 
production and reproductive performance 
in periparturient cows [7]. Omega-6 
fatty acids, in contrast, generate pro-
inflammatory responses. 
Clean, dry and well-ventilated bedding 
material is the most appropriate means to 
reduce environmental stress. High bacte-
rial counts in the bedding material relate to 
impaired udder health and depend on the 
type of material used. Organic material, 
e.g., recycled manure solids, seems to be 
more problematic than inorganic material, 
e.g., sand, because organic nutrients feed 
the bacterial load [8]. Therefore, content 
of organic-matter (best if less than 5%) 
and dry-matter (ideally more than 95 % 
respectively) are important [9, 10]. Longer 
lying times indicate better cow comfort 
and are associated with less lameness 
and higher milk yield. Yet, those cows 
have a higher risk of exposure to environ-
mental udder pathogens [11].
Finally, milking machines and the way they 
are used can have an influence on teat 
condition [12]. Making milking a regular, 
gentle, rapid and appropriate quarter 
routine, reduces udder stress. Overmilking 
subjects the quarter to tissue stress and 
has an impact on udder health, with 
exacerbation of other milking machine 
faults. Automatic milking machines, 
now employed worldwide, milk quarters 
separately with quarter-specific take-
off determination, thereby reducing the 
possibility of overmilking [13].
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”The elimination of an 
antibiotic shield does not 
necessarily have to result 
in a higher rate of new 
intramammary infections. 
By modifying the known risk 
factors and by optimising 
herd management, risk 
levels can be equally low 
as when prophylactic 
antimicrobials are used.”
María Sánchez Mainar
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Standard operating procedures and 
recommended practices on dairy farms are 
constantly evolving, driven by measurable 
animal welfare outcomes and societal 
pressures about what is acceptable to 
customers and consumers. 
In 2016, the U.S. dairy industry was 
presented with customer concern about 
tie stalls facilities due to the potential to 
limit freedom of movement. The National 
Dairy FARM Animal Care Program, 
administered by National Milk Producers 
Federation in conjunction with Dairy 
Management Incorporated, developed a 
task force to address the concern, as well 
as to develop Best Management Plans 
(BMP) for tie stalls facilities. A literature 
review was conducted to examine U.S. 
dairy farm demographics, animal welfare 
outcomes, and best management 
practices (BMP) for tie stalls facilities. 
Additionally, a comparison of animal 
welfare outcomes for tie stall facilities with 
other housing systems was conducted as 
well as the economic and societal impact 
of tie stall facilities.
The literature review concluded that tie 
stall facilities implementing BMPs provide 
equal opportunities of sound welfare for 
lactating dairy cattle compared to those 
housed in other facility types. Animal 
morbidity, mortality, BCS, hygiene, and 
locomotion score of 1 (Table 1) are similar 
in tie stall and freestall systems. Tie stalls 
tend to have a greater percentage of cows 
with a hock and knee score (Table 2; 7.2 
vs. 2.1%) and hygiene score of 3 as (17.3 
vs. 10%) compared with freestall systems. 
Approximately 50% of all tie stall facilities 
are operated by a plain sect community 
member representing more than 9,000 
dairy farms with 21,000 employees. 
More research is needed to evaluate the 
welfare of cows that are housed in tie 
stalls and compare these values to those 
in other housing systems. Results of this 
analysis will be used to enhance the BMP 
of the sector in the United States dairy 
industry which manages dairy cattle in tie 
stall facilities [2].
A literature review of animal welfare outcomes 
by facility type in the United States
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Primary Housing Type
Tie stall or 
stanchion Freestall
a Open/dry lotb All operationsc
Locomotion 
scored % SE % SE % SE % SE
1 89.6 2.1 89.7 1.0 91.7 2.2 90.2 0.9
2 8.6 2.0 7.1 0.6 6.3 1.3 7.3 0.7
3 1.8 0.4 3.2 0.5 2.0 1.0 2.6 0.3
Total 100.0  100.0  100.0  100.0  
a Includes Freestall with no access to open/dry lot and Freestall with access to open/dry lot
b Includes Open/dry lot/multiple animal outside area without barn or shed (with or without shade structures) 
and Open/dry lot with open shed/loafing shed
c The All Operations category includes categories not presented in this table (those with Pasture and Other 
housing for lactating cows)
d Locomotion Scorecard 1 is sound, 2 is moderately lame, 3 is severely lame
Table 1 – Operation average percent cows by locomotion score, and by primary housing type used for 
lactating cows.
Primary Housing Type
Tie stall or 
stanchion Freestall
a Open/dry lotb All operationsc
Hock lesion 
scored % SE % SE % SE % SE
1 69.8 5.2 88.8 2.4 96.1 0.8 82.5 2.4
2  23.1 3.9 9.1 2.0 3.8 0.7 13.9 1.9
3  7.2 1.7 2.1 0.5 0.1 0.1 3.6 0.7
Total 100.0  100.0  100.0  100.0  
a Includes Freestall with no access to open/dry lot and Freestall with access to open/dry lot
b Includes Open/dry lot/multiple animal outside area without barn or shed (with or without shade structures) 
and Open/dry lot with open shed/loafing shed
c The All Operations category includes categories not presented in this table (those with Pasture and Other 
housing for lactating cows)
d Hock and Knee Lesion Scorecard 1 is no hair loss/swelling, 2 is some hair loss; no swelling, 3 is severe 
swelling and/or abrasion through hide
Table 2 – Operation average percent cows by hock lesion score, and by primary housing type used for 
lactating cows.
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Road mapping ensures 
systematic empowerment of 
employees in the dairy farm
Level Learning goals Deadline Responsible
5
• Can do all the milking routines in the milking parlour 
• Milking of cows treated with antibiotics and handling the milk correctly
• Can train other milkers on level 1–4
• Can pass on information from the milking and the work of other milkers
4
• Can do all the milking routines in the milking parlour, though with the support from a super-milker 
• Can service the whole milking parlour before and after milking
• Can assess the cloths after wash
3
• Can assess if cows have finished milking 
• Knows the action plan for what to do when you find a cow with mastitis
• Can start the milking system
• Can change the milk filter
• Can handle the milking cloths when using them for milking
2
• Can assess a cow with mastitis
• Can do the right milking routine with the right interval of 90–120 sec
• Can adjust the service-arm correctly after correct attachment of teat cups
1
• Can strip the teats correctly using 3–4 strong squirts from each teat
• Can prepare the cow with dip before and after milking
• Can use the correct cloth-technique
• Can attach the cluster without false air intake
Table 1 – Road mapping: Training levels for milkers.
The road mapping tool provides a struc-
ture for stepwise employee development 
so that they continuously undergo a learn-
ing process and upgrade their skills in a 
simple and comprehensive way. One of 
the challenges in today’s agriculture is en-
suring that employees continuously devel-
op their skills, thus raising the professional 
level of the farm. Most employees are in-
terested in learning more. In an American 
survey, 174 people were interviewed on 14 
farms [1]. Employees were asked whether 
they thought that their professional lev-
el met the demands of their work. They 
should respond to a scale of 1–5, where 1 
was ‘I know enough about my work’ and 5 
was ‘I am interested in the farm and I want 
to learn more’. The average result was 
4.73. In other words, there was a great 
deal of interest in learning more.
SEE EMPLOYEE POTENTIAL 
The farm owners or managers were also 
asked about their views on the employees’ 
interest in the work on the farm. Typically, 
they did not think that the employees 
were particularly interested apart from 
earning money. This result is food for 
thought since they completely ignore the 
enormous potential of their employees. 
Nevertheless, the author thinks there is a 
great potential in farm employees which is 
not being exploited, and many farms could 
create a win-win situation by being more 
systematic about employee education, 
as a higher level of knowledge results in 
greater understanding and better task 
performance. Vibeke Fladkjaer Nielsen is 
convinced that the employee’s interest 
in learning more is the same all over the 
world. The trick is to do it in small steps; 
this is the way people learn most quickly.
DEVELOPMENT STEP BY STEP WITH 
ROAD MAPPING
The perfect tool for meeting this goal and 
ensuring skill improvement of employees 
in a systematic way is road mapping. Road 
mapping divides the development that the 
individual employee is going through into 
different levels ranging from 0 to 5. At level 
0 the employee is aware of a (single) task 
while at level 5 the employee has all the 
skills that meet the farm goal. An example 
could be milking. Here, level 0 will typically 
be where the employee can wipe an udder 
and apply the cluster. At each subsequent 
level, new skills are added/required 
through which the employee can reach 
the next level. At level 5, the employee 
has a full understanding of the importance 
of proper milking and can make 
assessments in the milking parlour about 
the health of the cows. Road mapping is, 
in other words, a tool based on the level 
of employee competence. It provides a 
clear structure for stepwise development 
of employee skills, ensuring that the 
steps that are taken are not too big and 
yet providing sufficient development of 
particular skills. Thus, with a division into 
levels, the employee is guided through a 
learning process and upgraded in a simple 
and manageable manner. The content of 
each road map is, of course, dependent 
on the level of skills that the employee 
presently has at the farm as well as the 
level of skill he wants to achieve.
Below is presented an example of a road 
map for the milking parlour which is currently 
being tested by the author (Table 1).
V. Fladkjaer Nielsen, M.Sc. 
SEGES Livestock Innovation, Denmark
 vfn@seges.dk
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Antimicrobial resistance trends of 
Staphylococcus aureus isolated from 
bovine intramammary infections from 
1990 to the present time in Argentina 
Staphylococcus aureus is one of the most 
prevalent major mastitis pathogens in dairy 
herds worldwide [1]. Antimicrobial therapy 
is one of the bases of S. aureus mastitis 
control programmes, both for subclinical 
cases at drying off and clinical cases 
during lactation [1]. However, cure rates 
following antibiotic therapy are variable 
since several factors associated with 
host, pathogen and treatment regimen 
affect the probability of cure of S. aureus 
intramammary infection (IMI) [2]. Among 
pathogen factors, antibiotic resistance is 
an obvious reason for treatment failure, 
although selection of antibiotics based 
on in vitro susceptibility testing does not 
assure therapeutic success [3]. Despite 
this drawback, most authors agree that 
antibiotic susceptibility testing should 
precede antibiotic treatment, mainly 
in case of subclinical mastitis [2]. In 
addition, antimicrobial susceptibility 
testing is important for monitoring 
the spread of resistant strains among 
bacterial populations. Both determination 
of minimum inhibitory concentration 
(MIC) and disk diffusion test (DD), which 
is the most widely applied method in 
routine veterinary laboratories due to its 
simplicity and low cost, have been used 
for performing antimicrobial susceptibility 
surveys worldwide [4, 5]
The aim of this study was to review 
published research in Argentina on 
antimicrobial susceptibility of S. aureus 
isolated from bovine IMI. Searching for 
the survey included the words “mastitis”, 
“bovine”, “Staphylococcus aureus”, 
“coagulase-positive Staphylococcus”, 
“antimicrobial” “susceptibility” and 
“resistance”. Since previous reports 
indicated that the majority of coagulase-
positive Staphylococci isolated from 
bovine milk are S. aureus [1] studies 
which characterized the isolates either 
as S. aureus or coagulase-positive 
Staphylococci were considered. 
The inclusion criteria were: studies 
performed in Argentina which evaluated 
antimicrobial susceptibility of S. aureus 
isolated from mammary secretion quarter 
and composite samples of cows with 
subclinical and clinical mastitis using MIC 
determination or DD test published in 
peer reviewed journals. Scopus, PubMed, 
and Academic Google databases were 
searched for scientific papers unrestricted 
by language and published from 1990 to 
2018. A total of nine scientific publications 
which reported antimicrobial susceptibility 
of S. aureus isolated from bovine mastitis 
in Argentina is included (Table 1). Only 
those antibiotics included in at least three 
studies are shown in the table. 
DISCUSSION
There is a growing concern about overuse 
and misuse of antimicrobial products for 
treating and preventing infectious diseases 
in cattle due to its contribution to the 
emergence and spread of antimicrobial 
resistant organisms. These organisms 
represent a great threat to human and 
animal health, and to the world ecosystem 
[15]. Bovine mastitis is the most frequent 
reason for treating both lactating and non-
lactating dairy cattle [16, 17] There are no 
studies in Argentina and limited studies 
worldwide which compare resistance 
patterns before and after antibiotic 
usage throughout years using consistent 
procedures to evaluate the emergence 
of resistance due to antibiotic usage [16]. 
However, several studies have described 
occurrence of S. aureus resistance to 
antibiotics over time [5]. The antibiotics 
that were more consistently evaluated 
in Argentina were the beta-lactams and 
those of the macrolide-lyncosamide class. 
Penicillin is considered a first choice 
antibiotic for treating bovine mastitis. 
Resistance to penicillin has varied among 
studies showing the highest percentages 
during the first two decades (1990–
2000) and lower percentages in studies 
conducted in the current decade. Only in 
one study, published in 2001, oxacillin-
resistant coagulase-positive Staphylococci 
were detected, indicating that it could 
have been an isolated finding. However, 
since methicillin-resistant S. aureus have 
been detected in several countries [18], 
continuous surveillance is needed for early 
detection of emergence of this type of 
resistance.
Antibiotics from macrolide-lyncosamide 
class are frequently used in Argentina for 
treating bovine mastitis [17]. Erythromycin 
is the most commonly tested macrolide 
as representative of this group, using 
approved human interpretive criteria [19]. 
Resistance to erythromycin was low in 
most studies. Only in one study in the 
last decade did it exceed 20%, which is 
higher than percentages reported both in 
Argentina and other countries [5]. Pirlimycin 
was commercially available in Argentina 
during the 90s, and has recently been 
introduced again to the veterinary market. 
Susceptibility to this antibiotic was reported 
in studies published at the beginning of 
the 2000 decade using veterinary-specific 
interpretive criteria [19], showing variable 
resistance among studies and percentages 
comparable with previous reports in other 
countries [5]. 
In conclusion, although information is 
limited, there is no apparent emergence or 
progression of S. aureus resistance to the 
most commonly used antibiotics for treating 
bovine mastitis in Argentina. This finding 
is in accord with previous reports which 
included studies conducted in different 
countries [5, 16]. However, there is a need 
to extend these studies to other bovine 
mastitis pathogens, using a harmonized 
approach to allow measuring resistance 
trends over time [15]. This information, 
together with increasing knowledge about 
antibiotic usage in dairy farms in Argentina 
[17] will allow us to evaluate and propose 
actions for a more responsible and prudent 
use of antibiotics in our dairy farms.
2018 IDF Animal Health Report • Issue N°1228
I. Molineri Ana1, 2, V. Neder1, 
L. F. Calvinho1, 3
1Estación Experimental Agropecuaria 
Rafaela, Argentina, 2Consejo Nacional 
de Investigaciones Científicas y 
Tecnológicas, Argentina 3Universidad 
Nacional del Litoral,  argentina 
calvinho.luis@inta.gob.ar
REFERENCES
1. Barkema, H.W., Schukken, Y.H. & Zadoks, R.N. 
(2006) The role of cow, pathogen, and treatment 
regimen in the therapeutic success of bovine 
Staphylococcus aureus mastitis. J. Dairy Sci. 
89:1877–1895
2. Calvinho, L.F., Vitulich, C.A., Zurbriggen, M.A., de 
Canavesio, V., Tarabla, H.D. (1991a) Prevalence of 
udder pathogens in dairy herds from the Santa Fe 
dairy area (In Spanish). Therios 18:188–96.
3. Calvinho, L.F., Delgado, A.R., Vitulich, C.A., Oc-
chi, H.L., de Canavesio, V., Zurbriggen, M.A., 
Tarabla, H.D. (1991b) In vitro susceptibility to 
antimicrobials of udder pathogens isolated from 
clínicas mastitis from dairy herds of Santa Fe dairy 
área. (In Spanish) Vet. Arg. 8:677–680.
4. Calvinho, L.F., Toselli, F.G., Weinmann, W.R., 
Canavesio, V.R., Neder, V.E., Igusquiza, I.A. (2002) 
Antimicrobial susceptibility of coagulase-posi-
tive Staphylococcus isolated from bovine mastitis 
in the Central dairy area of Argentina. (In Spanish). 
Rev. Arg. Microbiol. 34:171–175.
5. CLSI (Clinical and Laboratory Standards Institute). 
(2013) Performance standards for antimicrobial 
disk and dilution susceptibility tests for bacteria 
isolated from animals. Clinical Laboratory Stand-
ards Institute, Wayne, PA, USA. 2013; Vol. 28, No. 
8. 4th ed. Approved standard, VET01-A4.
6. Erskine, R.J., Walker, R.D., Bolin, C.A., Barlett, 
P.C., White, D.G. (2002) Trends in antibacterial 
susceptibility of mastitis pathogens during a sev-
en-year period. J. Dairy Sci. 85:1111–1118
7. Erskine, R., Cullor, J., Schaellibaum, M., Yancey, 
B., Zecconi, A. (2004) Bovine mastitis pathogens 
and trends in resistance to antibacterial drugs. 
National Mastitis Council Research Committee 
Report. In: NMC Annual Meeting Proceedings. 
Pg. 400–414.
8. Gentilini, E., Denamiel, G., Llorente, P., Godaly, S., 
Rebuelto, M., DeGregorio, O. (2000) Antimicrobial 
Susceptibility of Staphylococcus aureus Isolat-
ed from Bovine Mastitis in Argentina. J Dairy Sci 
83:1224–1227
9. González Pereyra, V., Pol, M., Pastorino, F., Herre-
ro, A. (2015) Quantification of antimicrobial usage 
in dairy cows and preweaned calves in Argentina. 
Prev. Vet. Med. 122:273–279.
10. Hoe, F.G., Ruegg, P.L. (2005) Relationship be-
tween antimicrobial susceptibility of clinical mas-
titis pathogens and treatment outcome in cows. 
J.A.V. M. A. 227:1461–1468
11. Huber, H., Koller, S., Giezendanner, N., Stephan, 
R., Zweifel. C. (2010) Prevalence and characteris-
tics of meticillin-resistant Staphylococcus aureus 
in humans in contact with farm animals, in live-
stock, and in food of animal origin, Switzerland, 
2009. Euro Surveill. 2010;15:1–4.
12. Micheo, C., Amand de Mendieta, V., Soriano, C., 
Tabera, A., Stefano, A., Casasnovas, G., Purrán, 
P., Corradeti, A., Carabajal, S. (2001) Study of in 
vitro susceptibility of bacterial strains isolated 
from bovine mastitis in Mar y Sierras dairy area. (In 
Antibiotic % Resistant
Penicillin 14.81 77.5 55.89 40.3 47.6 48.4 14.3 28.12 33.85
Oxacillin - - 2.94 0 0 0 - 0 0
Erythromycin - - 5.6 11.6 2 2.1 22.2 3.12 7.69
Pirlimycin - - 14.71 7.7 4 - - - -
N 33 79 34 206 101 95 63 96 65
Reference 1 2 3 4 5 6 7 8 9
Table 1 – Antimicrobial resistance of Staphylococcus aureus isolated from bovine mastitis in Argentina ([6, 7, 8, 9, 10, 11, 12, 13, 14].
Spanish). Vet. Arg. 18:588–597.
13. Neder, V.E., Araujo, L., Gianre, V.R., Calvinho, L.F. 
(2016) Antibiotic susceptibility of Staphylococ-
cus aureus isolated from bovine mastitis in dairy 
farms from the central dairy area of Argentina (In 
Spanish). REDVET Rev. Electrón. vet. Vol. 17 Nº 
9 - http://www.veterinaria.org/revistas/redvet/n09 
0916.html
14. Office International des Épizooties. (2016) The OIE 
Strategy on Antimicrobial Resistance and the Pru-
dent Use of Antimicrobials. www.oie.int/antimicro-
bial-resistance.
15. Oliver, S.P., Murinda, S.E. (2012) Antimicrobial 
resistance of mastitis pathogens. Vet. Clin. Food 
Anim.28:165–185.
16. Pellegrino, M.S., Frola, I.D., Odierno, L.M., 
Bogni, C.I. (2011) Mastitis bovina: resistencia 
a antibióticos de cepas de Staphylococcus au-
reus aisladas de leche. (In Spanish). REDVET Rev. 
electrón. vet. http://www.veterinaria.org/revistas/red- 
vet Volumen 12 Nº 7 - http://www.veterinaria.org/
revistas/redvet/n070711.html
17. Russi, N.B., Bantar, C., Calvinho, L.F. (2008) An-
timicrobial susceptibility of Staphylococcus au-
reus causing bovine mastitis in Argentine dairy 
herds. Rev. Arg. Microbiol. 40:116–119.
18. Srednik, M.E., Abate, S., Gentilini, E.R. (2016) 
Antibiotic susceptibility of Staphylococci isolated 
from milk samples obtained from bovine mastitis 
(In Spanish). In Vet. 18:39–44.
19. Zecconi, A., Calvinho, L., Fox, L. (2006) Staphylo-
coccus aureus intramammary infections. Bulletin 
of the International Dairy Federation. 408/2006. 
Pp 39. FIL-IDF. ISSN 0250–5118
29Research
The reality and perceptions of the 
South African dairy farmer regarding 
mastitis in 2016
SUMMARY
The South African dairy industry shows 
immense diversity. There are mastitis 
management practices, if consistently 
executed, which might improve udder 
health and milk flow, but prioritizing these 
for the diverse segments might be a 
challenge.
As is the case globally, the South African 
dairy industry is aware of and actively 
addressing the issue of AMR. The funding 
of this survey by the producer organization 
reflects this on-going commitment.
In 2015, an industry-funded project, 
Resistance to Available Antibiotics in 
Lactating Cows with Mastitis, was initiated. 
An important part of the project was a 
survey of management practices applied 
to South African dairies as they pertain to 
mastitis treatment and prevention.
In South Africa, four dairy regions can 
be described, roughly equating to the 
provinces of the Western Cape (WC), 
Eastern Cape (EC), Kwazulu-Natal (KZN) 
and the remaining provinces combined 
into a Central region (Figure 1). Most of the 
milk is produced along the coastline with 
more than 50% of the milk produced by 
grazing dairies with seasonal calving from 
June through to August (Figure 2). The 
global trend of increasing milk production 
with fewer dairy farms is also occurring in 
South Africa (Figure 3).
METHODS
An online survey was deployed to the 
Milk Producers Organization (MPO) [1, 
2] members of approximately 1,700 
dairymen in April (autumn) of 2016. Twenty 
of the surveyed farms, milking ≥ 200 
cows, were selected at random, 5 from 
each dairy region, for on-site visits where 
further data was collected. A software 
application (iPrep) was used to measure 
the timing between milking routine steps 
[3].
Results
Following vetting, 147 surveys (or 8.6% of 
the MPO) were eligible for analysis. Herd 
size for the survey averaged 448.5 ± 423.6 
SD (Figure 4) and was similar irrespective 
of the management type – pasture only 
(49%), pasture with concentrate and/or 
total mixed ration (TMR) (35%) and TMR 
only (16%). Jersey’s and Holsteins are 
equally popular.
When asked to describe their management 
style [3], an equal percentage of dairy 
farmers (± 45% each) considered 
themselves either low input, lower 
production or high input, higher production 
farms, relating to the intensity of their 
management. The average milk production 
was 18.2 L/cow/day (ranging from 7.0 to 
40.0 L/cow/day), average butterfat 4.24% 
and average protein 3.54%.
Parlour
A wide variety of parlour types are in use, 
with swing-over, herringbone and rotary 
being the most common. Milking routine 
steps and parlour procedures [5] are 
compared with international data in Tables 
1 and 2. Approximately 50% of dairy farms 
pre-dip, lower than in some other parts 
of the world and approximately a third of 
producers either do not strip or wipe and/
or do not use gloves.
Besides the individual steps of a milking 
routine, the timing between them is 
important [6]. Timing was erratic within 
and between most of the dairy farms 
visited (Table 1). Allowing for an ideal 
stimulation time of between 60 to 120 
seconds, only 11.1% of rotary and 18.2% 
of other parlours were in this range.
Udder health
The average bulk milk somatic cell count 
(BMSCC) was 287 ± 98 x 103 SD and 
were similar for the management types 
and regions (Figure 5). Fifty-three percent 
of farms participate in a milk recording 
scheme (Table 2), higher than that reported 
for the industry as a whole (± 20%). About 
two-thirds of dairymen routinely identify 
cows with an elevated somatic cell count 
(SCC) either testing individual cows and/or 
Figure 1 – The four dairy regions in South Africa.
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groups (Table 2). Of these, two-thirds consider cows with a SCC 
≥ 500 000 cells/ml eligible for treatment.
Udder cleanliness reported in the survey was similar to that 
recorded on the herds visited. In contrast, in an earlier study, 
a greater number of teat-ends scored 3 and 4 on herds visited 
compared to the survey herds [7]. The regular trimming of tail 
switches is implemented on roughly two-thirds (65.2%) of 
dairies, yet only 1.0% reported clipping or flaming udders [8].
Mastitis
The mastitis incidence of 31.8% is higher than the median of 
20% to 25% seen elsewhere in the world [9, 10] and ranged from 
3.5% to 93%. The average cull rate due to mastitis was 6.9%, 
lower than the target upper limit of 15% [11] and ranging from 
0.7 to 27.8%.
Milk samples for culture and microbial identification were 
collected on 29.2% of farms and 20.2% requested antimicrobial 
sensitivity. In contrast, in the USA, 68% of dairymen always 
submit samples for culture and identification or at the least 
some of the time [12]. In this study, the majority of dairymen treat 
mastitis with intramammary antibiotics (86.3%), of which half 
also use injectable antibiotics (49.3%) (Table 3). 
The three most commonly isolated mastitis causing bacteria 
reported were, in decreasing order, Staphylococcus aureus, 
Escherichia coli and Streptococcus uberis. In contrast, 
bacteriology of high cell count, normal appearance milk showed 
coagulase-negative staphylococci, Staphylococcus aureus 
and Streptococcus agalactiae have been shown as the most 
common [13].
One-fifth of South African dairymen reported using antibiotics in 
an off-label manner (including higher dosage, shorter treatment 
intervals and/or an extended duration of treatment), not always 
doing so under the direction of a veterinarian (Table 3). The 
efficacy of using of injectable antibiotics, at 49.3%, must be 
questioned.
Dairy farmers’ attitudes toward mastitis are shared in Figure 6, 
with only a third of dairy farmers feeling that they had enough 
knowledge regarding mastitis, a result similar to Jansen et al. 
[14]. 
Additional information, directly or indirectly, linked to mastitis is 
shown in Table 4, showing typical lengths of the dry and steam-
up/close-up periods. There might be an opportunity to feed 
higher levels of Vitamin E during the steam-up/close-up period.
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Figure 2 – The distribution of dairy cows in South Africa
Figure 3 – The trend of dairy farm numbers and milk production 
in South Africa.
Figure 4 – Herd sizes in the different dairy regions in South Africa 
as compared to the Milk Producers’ Organization census numbers.
Figure 5 – Bulk milk somatic cell counts on South African dairy 
farms.
Figure 6 – South African dairy farmer attitudes regarding mastitis.
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MILKING ROUTINE TIMING (sec ± SD)
TIME Survey only (24) Farms (20) Rotary (9) Other (11)
Pre-dip kill time 
(30 sec)
22 ± 15 74 ± 51 54 ± 31 87 ± 58
Stimulation to 
attach (90 sec)
N/A 92 ± 77 77 ± 65 100 ± 85
Entrance to 1st 
touch (42-54 sec)
N/A 112 ± 99 73 ± 29 144 ± 127
Table 1 – The timing of the important milking routine steps on South African dairy farms.
SUBCLINICAL MASTITIS – SCC MONITORING %
Individual cow or group (88 respondents) 67.1
As needed (58 respondents) 39.7
Twice or more per year (58 respondents) 60.3
By California Mastitis Test (63 respondents) 51.0
By milk testing agency (63 respondents) 49.0
Quarter samples (46 respondents) 50.0
Whole herd testing (83 respondents) 53.0
Frequency every milk test or more (44 respondents) 63.6
Routinely treat high SCC cows (52 respondents) 67.3
Table 2 – Findings related to subclinical mastitis in South Africa.
SUBCLINICAL MASTITIS – SCC MONITORING %
Dry period length in days (87 respondents) 61.6
Have a steam-up group (110 respondents) 69.1
Duration of the steam-up period in days (68 respondents) 23.3
Feed anionic salts (37 respondents) 51.4
Measure urine pH (27 respondents) 18.5
Feed additional Vit E (68 respondents) 11.8
Average days in the hospital (58 respondents) 6.4
Mastitis cows kept segregated (90 respondents) 58.9
Waste milk fed to calves (82 respondents) 36.6
Vaccinate for mastitis (83 respondents) 10.8
Use a veterinarian (106 respondents) 77.4
Veterinary visits monthly or more frequent (78 respondents) 64.1
Considers the veterinarian qualified (a dairy “specialist”) (81 respondents) 82.7
Demographics
Average number of years in the dairy industry (147 respondents) 23.6
Dairyman of age < 50 (143 respondents) 51.8%
Hands-on time owners spend with their cows every day (hrs) (144 respondents) 4.36
Table 4 – Other interesting mastitis-related findings, revealed by the survey.
MASTITIS TREATMENT & PREVENTION %
Routinely treat mastitis with antibiotics (79 respondents) 92.4
Use an intramammary antibiotic (73 respondents) 86.3
Use an injectable antibiotic (73 respondents) 49.3
Use an anti-inflammatory (36 respondents) 63.9
Use extra-label treatments (72 respondents) 19.4
Extra-label treatment is authorized by veterinarian (9 respondents) 33.3
Use dry treatment (114 respondents) 88.6
Table 3 – Findings related to mastitis treatment and prevention
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Selective Dry Cow Treatment 
in Dairy Cows
Udder health is associated with mastitis 
management, of which blanket dry cow 
treatment (BDCT) has been an important 
part for decades. To prevent the udder 
from new intramammary infections during 
the dry period, the use of BDCT has been 
advocated for more than 50 years as the 
best dry cow treatment (DCT) practice and 
part of the five-point mastitis prevention 
programme to reduce the prevalence of 
intramammary infections by eliminating 
infections already present at drying off 
and by preventing new infections from 
occurring during the dry period. Since 
2012, preventive use of antimicrobials 
in veterinary medicine is prohibited in 
the Netherlands. Therefore, BDCT has 
been replaced by treatment of infected 
cows only, known as ‘selective dry cow 
treatment’ (SDCT). Although selection of 
cows is an important part of SDCT and 
has a great effect on the consequences, 
not much research had been done in 
this field. Therefore, the effect of various 
approaches to select cows for DCT 
on parameters such as udder health, 
antimicrobial use (AMU) and economics 
was evaluated. 
This PhD thesis quantified the effects of 
SDCT on clinical and subclinical mastitis, 
AMU, economic consequences of the use 
of antimicrobials and farmers’ attitude. 
The effect of different somatic cell count 
(SCC) threshold-scenarios for selecting 
cows for DCT on these parameters were 
evaluated. 
The effect of SDCT was evaluated in 1,657 
cows in 97 Dutch dairy herds, that all 
had a low SCC at the last milk recording 
before drying off. A split-udder design was 
used in which two quarters of each cow 
were treated with dry cow antimicrobials 
and the other two quarters remained as 
untreated controls. Low SCC was defined 
PHD REPORTS 
as <150,000 cells/mL for primiparous and 
<250,000 cells/mL for multiparous cows [1].
The incidence rate of clinical mastitis 
was found to be 1.7 times higher in 
quarters dried off without antimicrobials 
as compared to quarters that were dried 
off with antimicrobials. Streptococcus 
uberis was the predominant organism 
causing clinical mastitis in both groups. 
SCC at calving and at 14 days in milk 
was significantly higher in quarters dried 
off without antimicrobials (772,000 cells/
mL and 46,000 cells/mL respectively) as 
compared to the quarters dried off with 
antibiotics (578,000 cells/mL and 30,000 
cells/mL respectively). Quarters with 
an elevated SCC or a positive culture 
for major pathogens at drying off had a 
higher risk for a SCC above 200,000 cells/
mL at 14 days in milk, as compared to 
quarters with a low SCC and a negative 
culture for major pathogens at drying off. 
For quarters that were culture positive for 
major pathogens at drying off, a trend for 
a higher risk of clinical mastitis was also 
found [1].
Selective dry cow treatment, not using 
dry cow antimicrobials in cows that had 
a low SCC at the last milk recording 
before drying off, significantly increased 
the incidence rate of clinical mastitis 
and the SCC after calving. The decrease 
in AMU by not applying SDCT was not 
compensated by an increase in AMU for 
treating clinical mastitis. The total AMU 
related to mastitis was reduced by 85% in 
these quarters [1].
Although differences were small, BDCT 
was, from an economical perspective, 
not the optimal DCT approach. In herds 
with a lower bulk milk SCC, more dry cow 
antimicrobials can be omitted without 
economic consequences, thus leading 
to lower costs. The economic impact 
of reducing the percentage of clinical 
mastitis was found to be much larger than 
that of reducing the bulk milk SCC. The 
optimal percentage of cows to be dried off 
with antimicrobials depends on the udder 
health situation, indicated by the bulk milk 
SCC and the incidence of clinical mastitis. 
For all evaluated types of herds SDCT was 
economically more beneficial than BDCT, 
in particular, if bulk milk SCC and clinical 
mastitis incidences are lower. Therefore, 
there is no evidence that economically, a 
change in the BDCT routine to reduction of 
AMU by applying SDCT [3] is detrimental.
More insight into the level of implementation 
of SDCT in the Netherlands was obtained 
via a questionnaire. The main criterion 
indicated by the farmers to be used to 
select cows for DCT was the SCC history 
during the complete previous lactation. 
There were no significant differences 
in udder health parameters between 
”Farmers’ and veterinarians’ 
mindset towards reduction 
of antimicrobials is crucial for 
successful implementation 
of a selective dry cow 
therapy strategy.”
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herds that applied BDCT or SDCT, nor 
between SDCT herds with high or low 
use of dry cow antimicrobials. Overall, 
AMU was higher in herds which applied 
BDCT, although there were no significant 
differences in intramammary treatment 
with antimicrobials other than DCT [4].
CONCLUSIONS
This thesis showed that reduction of AMU 
at drying-off leads to an increased risk of 
mastitis at the individual level. The effect 
at the herd level was, however, very small. 
Criteria chosen to select cows for DCT 
had a limited effect on udder health, while 
the effect on the amount of AMU was 
large. Economics was found not to be an 
argument not to reduce the use of DCT 
by applying selective dry cow treatment, 
because in almost all scenarios SDCT was 
economically beneficial over BDCT. 
Application of SDCT appeared to 
be associated with farmers’ and 
veterinarians’ attitude. Their mindset 
towards reduction of AMU is crucial for 
successful implementation of a SDCT 
strategy. 
C. Scherpenzeel, DVM, PhD
GD Animal Health, Deventer, 
the Netherlands
 c.scherpenzeel@gdanimalhealth.com
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Mastitis - an inflammatory response 
to infection of a cows’ udder - is a 
prevalent disease and has considerable 
negative economic and animal welfare 
consequences for the dairy industry. 
Despite the many preventive efforts, 
it remains one of the most common 
diseases in dairy cows. In situations of 
any high disease prevalence, like mastitis, 
selection for the recoverability of animals 
should be, therefore, of interest. This 
PhD project explores ways to improve 
the genetic evaluation of udder health 
by introducing methods and models 
which can make use of the information 
contained in recoverability from mastitis 
in addition to the information contained in 
susceptibility to mastitis.
At the beginning of the PhD project 
[1], extensive simulation analyses were 
performed to develop a bi-variate model for 
joint genetic evaluation of susceptibility to 
- and recoverability from mastitis. Mastitis 
incidences measured via the number of 
somatic cells in a millilitre of milk (typically 
used as an indicator for mastitis), were 
simulated and a transition model was 
applied to define traits of interest. The 
somatic cell count (SCC)-based mastitic 
or healthy states were converted to 
two series of transitions indicators: one 
for healthy to diseased (HD, to define 
mastitis susceptibility) and the other 
for diseased to healthy (DH, to define 
recoverability). The traits were analyzed 
with a bivariate threshold sire model 
using the Bayesian statistics approach in 
DMU [2]. The study [1] demonstrated that 
both traits can be modelled jointly, and 
simulated correlations could be correctly 
reproduced.
In the second study of the PhD project [3], 
the bivariate model developed through 
simulation with added systematic effects 
and a function of time was applied to real 
data extracted from Danish dairy herds 
database connected to VMS milking 
robots (Voluntary Milking System, DeLaval 
International AB, Tumba, Sweden). The 
SCC measured via cell counters attached 
to the milking robots, was analyzed 
in a novel way, using time-to-event 
Figure 1 – Posterior distributions of heritability estimates from a Markov chain Monte Carlo sample size 
of 5,000 for susceptibility (HD, gray and overlapped area) to - and recoverability (DH, blue and overlapped 
area) from mastitis.
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analyses. Findings in this study indicate 
that recoverability is as heritable as 
susceptibility (Figure 1), suggesting that 
the trait can be improved by breeding. The 
genetic correlation between susceptibility 
to - and recoverability from mastitis was 
-0.83, implying that cows that are resistant 
to mastitis also recover faster.
In the third study [4], genome-wide 
association studies were conducted to 
find positions on the genome that affect 
HD and/or DH. Single SNP regression 
analysis was performed, and the 
substitution effect of each SNP was tested 
with a t-test. Contrary to the observed high 
negative genetic correlation in the second 
study, association signals were mapped 
in different locations, suggesting that 
the traits could be regulated by different 
genes. Moreover, complexity of the traits 
was manifested with the absence of strong 
association signals (Figure 2) suggesting 
that numerous genes with small effects 
could be involved in both directions of the 
disease.
Although susceptibility to - and 
recoverability from mastitis are strongly 
negatively correlated, recoverability has 
a similar size of genetic component as 
susceptibility and could be considered 
a new trait for selection. Modelling and 
analyses of the genetics of recoverability 
could be of specific benefit in situations 
of high disease incidence. The PhD 
project has introduced a method for 
joint estimation of breeding values for 
susceptibility to - and recoverability from 
mastitis. With regard to introduction of 
recoverability or modelling both directions 
of mastitis, this thesis is novel in the area 
of genetic evaluation of udder health. 
This innovative modelling and approach, 
if adopted, should enhance the genetic 
evaluation of disease data through its ability 
to capture time-dependent and additional 
information not only from susceptibility to 
- but also from recoverability from a given 
disease, specifically mastitis.
The PhD project [5] was part of the 
Erasmus Mundus joint doctorate program 
‘EGS-ABG: European Graduate School in 
Animal Breeding and Genetics’.
B.G. Welderufael
College of Dryland Agriculture and 
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Towards the end of the PhD project [5], a 
more dynamic health classification, which 
took severity of possible infection into 
account, was introduced. Considerable 
genetic variance was detected for cows’ 
presence in health classes defined for 
longer periods, whereas the variations in 
health classes defined for short-term and 
sudden changes (e.g., acute) were mostly 
attributed to environmental factors.
“One of the challenges in 
today’s agriculture is ensuring 
that employees continuously 
develop their skills, thus 
raising the professional 
level of the farm.” 
Vibeke Fladkjaer Nielsen
Figure 2 – Manhattan plot of genome-wide associations with susceptibility (HD) to – and recoverability 
(DH) from mastitis. The blue line represents suggestive significance level [–log10(P-value) = 4] [4].
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Testing of milk samples fails to 
detect on-going Mycoplasma bovis 
infections in dairy herds 
Mycoplasma bovis (M. bovis) is a small 
bacterium capable of causing disease in 
cattle of all ages. It is part of the bovine 
respiratory disease complex and also 
associated with arthritis and otitis media 
in calves. In cows, the usual clinical 
presentation is mastitis and pneumonia, 
while arthritis is increasingly being 
reported. Since the first isolation in the 
USA in 1961, it has spread to many 
countries and is now endemic in many 
regions, including Europe. Over the last 
two decades, M. bovis has gained more 
attention due to its apparently increasing 
prevalence, intensified severity of the 
clinical signs and greater antibiotic 
resistance in recovered M. bovis isolates. 
The traditional way of diagnosing M. 
bovis has been bacterial culture of milk 
or other body fluids. However, easier and 
less expensive diagnostic test methods 
are requested for cows with arthritis 
or other systemic clinical signs of M. 
bovis-associated disease. In Denmark, 
serological assays such as ELISA are 
frequently used for testing dairy cows for 
other diseases, because they are relatively 
inexpensive per test and convenient, 
especially if applied to milk samples 
routinely collected for other purposes.
A study of factors influencing the M. bovis 
ELISA optical density measure (ODC%)1, 
which indicates the level of antibodies 
directed against M. bovis, in bulk tank milk 
(BTM) found that the prevalence of test-
positive lactating cows was correlated 
with the BTM ODC%. For each 10% 
increase in the prevalence of milk-test 
positive lactating cows, the BTM OCD% 
went up by 9 ODC% on average [1]. 
However, it became obvious that clinical 
signs consistent with M. bovis were 
reported by farmers even in herds during 
periods with low ODC%-values measured 
in BTM (Figure 1). To pursue explanations 
for the observed dynamics of BTM ODC% 
and associations with underlying infection 
patterns, investigations of the antibody 
responses in individual cows with different 
clinical signs were warranted. 
This was approached through an 
observational longitudinal study in four 
dairy herds with acute outbreaks of M. 
bovis-associated disease. The cows 
were divided into different disease groups 
based on the observed clinical signs, 
and the pattern in antibody responses 
in serum and milk were associated with 
the time since the clinical signs were 
first observed. The antibody response 
measured by the ELISA2 was generally 
very dynamic, short-lived and dependent 
upon the observed clinical signs. Even in 
systemically diseased cows, the average 
estimated ELISA ODC% was below the 
recommended cut-off at 37 ODC% 60–70 
days after clinical signs were observed for 
the first time (Figure 2). This makes the 
antibody response to M. bovis much more 
dynamic than seen for other diseases and 
means that frequent monitoring would be 
necessary to detect emerging M. bovis 
infection in the herd [2].
The ODC% in serum was primarily 
elevated in cows with clinical signs of 
systemic M. bovis-associated disease, 
while the ODC% in milk was mostly 
elevated in cows with mastitis and 
M. bovis PCR-positive milk samples. 
These findings suggest that secretion of 
antibodies against M. bovis in different 
fluids differ depending on clinical signs, 
making milk samples merely useful for 
detecting M. bovis udder infections [2]. 
In addition, differences were found when 
looking at the PCR results. Despite the 
fact that some cows with arthritis, or with 
non-specific or no clinical signs, were 
below the recommended PCR-cut-off at 
Ct-value 37, the cows with mastitis were, 
in general, clearly further below the cut-off 
(i.e., more clearly test positive) (Figure 3). 
Figure 2 – Descriptive statistics showing the bulk tank milk Mycoplasma bovis ELISA optical density 
measurement (ODC%) plotted against the apparent milk prevalence of antibody-positive lactating 
cows. Modified from Figure 2 in Petersen et al. 2016, Factors associated with variation in bulk tank milk 
Mycoplasma bovis antibody-ELISA results in dairy herds. J. Dairy Sci. 99:3815–3823.
”The findings of these 
studies are important to the 
dairy sector, because they 
highlight the difficulties in 
diagnosing M. bovis in dairy 
herds, especially when using 
primarily milk samples.” 
Mette Bisgaard Petersen
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This indicates that PCR in milk samples 
are also primarily suitable for detecting M. 
bovis udder infections and not M. bovis-
associated disease or infection in general.
The findings of these studies are important 
to the dairy sector because they highlight 
the difficulties in diagnosing M. bovis 
in dairy herds, especially when using 
primarily milk samples. If only relying on 
milk samples, many cases are likely to 
be overlooked, because both individual 
and BTM samples reflect the presence 
of M. bovis udder infections among the 
cows and not all other clinical syndromes 
in cows. Hence, diagnosing M. bovis in 
dairy herds often requires assessment 
of udder infections as well as systemic 
infected animals, from e.g., antibody 
measurements in serum. The very 
dynamic nature of the antibody response 
to M. bovis and the clear difference related 
to different clinical signs were previously 
unclear and demonstrate the value of 
basic longitudinal studies. If a basic 
understanding of the diagnostic material 
or test is lacking, interpretation in different 
contexts and for different purposes 
challenging, and recommendations based 
on these might be incomplete or in the 
worst case, will be misleading.
M. Bisgaard Petersen1, K. Krogh2 
and L. Rosenbaum Nielsen1.
1University of Copenhagen, Denmark, 
2Ceva Animal Health, Denmark
 mbp@sund.ku.dk
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FOOTNOTES
1 BioX Bio K 302 ELISA kit, BioX Diagnostics, Bel-
gium
2 PathoProof Major-3 PCR kit, Thermofischer Sci-
entific, USA
Figure 2 – Estimated mean antibody response in serum (solid line) and 95% confidence intervals (shaded 
area) as measured by the BioX ELISA Bio K302. Red represents the ‘Systemic’ group, blue is the ‘None’ 
group and black is the ‘Non-specific’ group. The dotted red line shows the recommended ELISA cut-
off (37 ODC%). Modified from Figure 3 in Petersen et al. 2018: A longitudinal observational study of the 
dynamics of Mycoplasma bovis antibodies in naturally exposed and diseased dairy cows. J. Dairy Sci. 
https://doi.org/10.3168/jds.2017–14340.
Figure 3 – Distribution of milk PCR cycle threshold (ct) values for Mycoplasma bovis divided into five 
disease groups of dairy cows from four Danish herds. Horizontal dotted lines show the recommended 
PCR cut-off (37 ct) under which a sample result is considered test-positive. Results from the same cow 
are linked by lines. ‘Dual-syndrome’ cows: cows with clinical signs of both arthritis and mastitis. ‘None-
group’ cows: no clinical signs which are likely to be associated with M. bovis. ‘Non-specific cows’: clinical 
signs which are not typical for M. bovis, but where M. bovis could not be excluded.
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Figure 1 – The prevalence of oestrous symptoms out of total oestrouses per breed (Swedish Red and 
White, red bar, and Swedish Holstein, black bar) and housing system (tie-stall, vertical pattern bar and 
loose-housing, diagonal pattern bar).
A stronger oestrous improves the 
fertility in dairy cows
Dairy cow fertility is of great importance 
to the economy of the dairy industry. The 
cows have to show oestrous, become 
pregnant and keep the pregnancy, as 
well as, calve within a certain interval 
and produce milk to be economically 
sustainable. In the Nordic countries fertility 
has been included in genetic evaluation 
since the 1970s. Traditional breeding 
includes fertility traits measures derived 
from insemination - and calving dates, 
which in general are highly influenced 
by on-farm decisions. Unfortunately, the 
low heritability of these traits makes the 
genetic improvement slow. 
Earlier studies have shown that fertility 
traits based on hormone levels, such 
as the progesterone level, have higher 
heritabilities compared to the classic 
fertility traits. Progesterone can be 
measured in milk, but tests and analyses 
are costly and labour intensive. This limits 
the opportunity to use these traits in a 
larger scale. 
SWEDISH RED COWS HAVE BETTER 
FERTILITY COMPARED TO HOLSTEIN 
COWS
In Sweden, artificial insemination (AI) is 
used and would be unsuccessful much of 
the time without oestrous synchronization 
and timed inseminations. Expression 
of oestrous symptoms is important for 
finding a cow in oestrous and for the 
correct timing of insemination. Weaker 
oestrous symptoms together with larger 
herds and fewer working hours per cow 
can result in reduced possibilities to find 
cows in oestrous. 
In the first part of her PhD project, Sofia 
Nyman looked at the oestrous intensity 
and duration, and the extent and pattern 
of pregnancy losses in the two main dairy 
breeds in Sweden, the Swedish Red 
and White (SRB) and Swedish Holstein 
(SH) breed [1]. The studies are based 
on ten different oestrous symptoms, 
progesterone measurements in milk and 
calving and insemination dates registered 
One explanation for this might be that 
weak oestrous intensity results in the 
incorrect timing of insemination. Silent 
oestrouses, which are ovulations without 
visible oestrous symptoms, are common 
in the first cycle. Oestrous intensity 
was found to increase with increasing 
ovulation number, while early embryonic 
loss and total pregnancy loss was found 
to decrease at later ovulations. Even 
though later inseminations could benefit 
in 2,000 oestrouses during 16 years at one 
of SLUs former research herds.
The first and most frequently observed 
oestrous symptoms in a coming oestrous, 
were red and swollen vulva, vaginal 
discharge and discharge colour and 
should not be neglected in the oestrous 
detection (Figure 1). To improve oestrous 
detection, automated registrations e.g., 
activity measures, together with visual 
observations could capture more oestrous 
symptoms. This could result in a better 
timing of the insemination. Generally, SRB 
cows, both tied and loose housed cows, 
had stronger and longer oestrouses, 
better pregnancy results and lower early 
embryonic losses compared to SH dairy 
cows, irrespective of milk production 
levels. 
Stronger oestrous intensity was found to 
decrease the amount of early embryonic 
loss from AI to day 24 after AI, but no 
effect was found after day 24 (Figure 2). 
“Several fertility traits, such 
as start of luteal activity and 
oestrous intensity, could be 
used in genomic selection 
where we can choose the 
best animals by looking at 
their DNA. Genomic selection 
is beneficial for traits with low 
heritability such as fertility.” 
Sofia Nyman
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the early embryonic survival it would be 
suboptimal in other aspects e.g., longer 
calving intervals. 
A SEARCH FOR GENETIC MARKERS TO 
IMPROVE FERTILITY
Following this study, Sofia Nyman 
investigated the possibility of using 
progesterone profiles to provide information 
for a genetic evaluation of fertility [1]. By 
using information about the DNA (genome), 
the genetic background for the variation in 
progesterone profiles between cows can 
be identified. Holstein-Friesian cows from 
four different countries were used in this 
study.
The shape of the progesterone profile 
during the oestrous cycle was found to 
be important for the pregnancy result. 
Deviations from the normal oestrous cycle 
can result in later inseminations, more 
inseminations and longer calving intervals, 
which can result in a lower milk production 
and negatively affect the profitability.
Two progesterone-based fertility traits, 
start of luteal activity (CLA) and delayed 
ovulations, were found to have higher 
heritabilities compared to the classic 
fertility traits which are used in for example, 
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Figure 2 – Oestrous intensity (solid line; right hand y-axis, 2 = weak to 4 = strong), early embryonic loss 
in (dotted line and square markers; left hand y-axis) and total pregnancy loss (dotted line and triangle 
markers; left hand y-axis) by ovulation number for Swedish Red and White and Swedish Holstein cows.
the Nordic genetic evaluation. These 
measurements were also found to be 
negatively affected by increased milk 
production and could deteriorate if not 
considered in the breeding evaluation.
In the analysis of the genome, five 
interesting regions on three chromosomes 
with genes connected to reproduction 
functions were found. Several fertility traits, 
such as CLA and oestrous intensity, could 
be used in genomic selection where we 
can choose the best animals by looking at 
their DNA. Genomic selection is beneficial 
for traits with low heritability such as 
fertility. Genomic selection requires large 
reference populations of cows that are 
genotyped and have registered traits 
e.g., automated registrations of oestrous 
symptoms and progesterone samples.
S. Nyman, PhD
Swedish University of Agricultural 
Sciences, Sweden.
 sofia.nyman@slu.se
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Takeaways from the 
6th ParaTB Forum
The 6th ParaTB Forum, promoted by the 
International Dairy Federation (IDF), was 
held on June 4th, 2018 at the International 
Convention Centre in Riviera Maya, Mexico. 
The Forum was comprised of more than 
25 delegates, representing 13 countries 
(Germany, Italy, Spain, the Netherlands, 
Ireland, Czech Republic, Brazil, Colombia, 
Canada, Australia, Argentina, Slovenia, 
and the United Kingdom). The Forum 
presents an opportunity for delegates to 
discuss and report on the current state 
of paratuberculosis research and control 
programmes in their home nations. This 
paper reviews some of the common 
themes and takeaways which emerged 
from the presentations [1].
INTRODUCTION
Paratuberculosis, also known as Johne’s 
disease, is a chronic, contagious 
bacterial disease of the intestinal tract 
which primarily affects sheep and cattle 
(most commonly seen in dairy cattle), 
goats as well as other ruminant species. 
Paratuberculosis is characterized by a 
slowly progressive wasting of the animal 
and increasingly severe diarrhoea. 
The disease is caused by a bacterium 
called Mycobacterium avium subsp. 
paratuberculosis (MAP)
There is no known treatment for the 
disease. Control involves good sanitation 
and management practices including 
screening tests for new animals to identify 
and eliminate infected animals and 
ongoing surveillance of adult animals.
CONTROL PROGRAMMES
The current status of paratuberculosis 
control programmes across the 13 
represented countries is quite varied. 
Several countries currently lack a formal 
established control programme (e.g., 
PAST & FUTURE IDF 
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”Countries with strong, active 
programmes are ones that 
are tightly linked to dairy 
processors and/or export 
markets. This level of interest 
among processors also 
serves to take a voluntary 
control and/or status 
programme and make it 
mandatory for farmers.” 
David Kelton
Colombia, Argentina, Czech Republic, 
Slovenia, Spain, Brazil), though active 
regional control efforts and research 
are underway. Further variation exists 
among countries with established 
control programmes, both in terms of 
their stage of development/maturity and 
their goals and objectives. For example, 
Canada’s voluntary control programme, 
though successful for many years during 
implementation, has waned in recent years 
due to reduced funding opportunities. 
However, Ireland has most recently 
developed and implemented a national 
voluntary control programme. Further 
still, control programmes in many other 
countries (e.g., Australia, the Netherlands 
and the United Kingdom) remain active 
and have matured over time.
Among those nations lacking a control 
programme, one of the primary barriers 
appears to be the national status of 
other important diseases of animal and/
or human importance, such as FMD, 
Brucellosis, BSE and TB. Many of these 
diseases have warranted more attention 
and funding and as a result, regionally 
organized schemes for paratuberculosis 
control have been deemed lower priority. 
Researchers from these countries are 
taking steps to document the current 
prevalence and disease burden that 
Johne’s disease presents to their nation’s 
ruminant populations. These efforts are 
aimed at raising the collective industry 
awareness and knowledge of the issue, 
and there is hope that this will further 
motivate interest in establishing more 
formal programmes for control. 
Key drivers for the implementation of 
regional/national control programmes 
appear to be related to growing industry 
concerns about the zoonotic potential 
of MAP, the desire to be proactive in 
control at both the farmer and processor 
levels, and/or to meet trade requirements. 
Countries such as Ireland and Canada 
have implemented programmes aimed 
at taking a proactive approach, but 
without a specific processor mandate or 
expectation. However, as documented, 
Canada has seen a decrease in investment 
and participation over time. Perhaps 
most interestingly, countries with strong, 
active programmes are ones which are 
tightly linked to dairy processors and/
or export markets. For example, the 
Netherlands and the United Kingdom 
have seen strong processor interest in 
establishing herd status programmes, so 
they can differentiate their products. As a 
result, there appears to have been strong 
motivation to participate in the control 
programmes. This level of interest among 
processors also serves to take a voluntary 
control and/or status programme and 
make it mandatory for farmers. Other 
countries, such as Canada and Ireland, 
have not yet seen this sort of uptake. 
TOOLS
The primary tools used for control across 
countries tend to revolve around a wide 
range of testing options, on-farm risk 
assessments, incentive programmes, 
education and awareness campaigns 
and vaccination (in a few instances). 
All countries recommend some form 
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of testing; from faecal culture or PCR 
of environmental samples to bulk tank 
milk ELISA tests, to the use of similar 
methods at the cow-level. More recent 
developments and variations exist in 
the use of a combination of tests (e.g., 
ELISA followed by direct faecal PCR for 
confirmation) and/or cut-off values (e.g., 
test label vs. cut-off for high shedding 
animals). Many nations supplement these 
testing schemes with the recommendation 
to complete a herd-level risk assessment. 
In certain cases, the risk assessment 
instruments are unique to Johne’s 
disease, while industry’s in other nations 
(e.g., Australia, Canada) are starting 
to adopt more general biosecurity risk 
assessments.
Most countries acknowledged that a 
primary programme challenge has been 
producer willingness to participate and/
or adopt changes. The use of incentives 
and/or regulations are the most common 
tactics used to motivate participation and 
adoption. These represent the traditional 
industry ‘carrot and stick’ levers utilized to 
influence change, and while it is clear that 
these methods are effective for certain 
subsets of populations and regions, they 
are not wholly adequate. Certain nations 
are relying on other industry influencers, 
such as milk processors and/or herd 
veterinarians, to play a role. As discussed 
above, the role of the processor has 
been highly influential. The role of the 
veterinarian, and other herd advisors, 
is complex. Buy-in and support among 
these groups has led to enhanced 
participation in control schemes; however, 
a lack of buy-in among certain groups 
has created a significant barrier to 
participation. Certain nations have begun 
to focus on research and development 
of tailored education, awareness and 
training methods which seek to engage 
and motivate these advisors. Additional 
approaches have focused on the use of 
social science methodologies, such as 
peer-learning and participatory extension 
approaches, to understand producer and 
advisor mindset and their interactions, and 
use this information to motivate change. 
A CALL TO ACTION
The Forum presentations and subsequent 
discussions clearly demonstrate that the 
current state of paratuberculosis control 
around the world is highly variable. The 
relative size and maturity of industry 
groups and the regional governments 
are important fixed characteristics which 
can act as motivators or barriers of 
control programme adoption. However, 
factors such as perceived priority, 
and the attitudes and knowledge of 
paratuberculosis as a problem, represent 
important variable characteristics which 
we have the power to influence. 
If Johne’s disease is ignored, there is 
clear evidence that the prevalence will 
increase; particularly in regions where 
there is significant animal movement. The 
good news is that many countries are 
demonstrating a decrease in herd and 
animal prevalence of paratuberculosis. 
Several nations have established status/
control programmes and have engaged 
numerous industry stakeholders in the 
design, implementation and support of the 
programme - engagement which is crucial 
to the long-term sustainability of the 
programme. Furthermore, those without 
formal programmes are taking proactive 
steps to provide evidence of the problem 
and influence industry stakeholders 
towards adoption. 
This Forum has presented a unique op-
portunity for the sharing of past, present 
and future perspectives on paratubercu-
losis control and serves as an incredibly 
important catalyst for engaging in mean-
ingful international discussion about how 
to address this globally important issue. 
Much like our recommendations to pro-
ducers to ‘stay the course’ and make Joh-
ne’s disease control a long-term goal, we, 
along with our industry, government and 
academic partners, must adopt a long-
term vision towards the prevention and 
control of Johne’s disease.
David Kelton1, DVM, PhD and 
Steven Roche1, 2, DVM, PhD
1 Department of Population Medicine, 
Canada, 2 ACER Consulting, Canada
 dkelton@uoguelph.ca 
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The 2019 IDF Mastitis Conference
The next IDF Mastitis 
Conference will take place 
from 14 to 16 May 2019 in 
Copenhagen, Denmark. It 
will be hosted by the Danish 
farmers organization SEGES 
in collaboration with various 
research and development 
institutions.
The conference will gather experts from 
around the world, with knowledge and 
passion for udder health and milk quality. 
We expect around 400 participants from 
academia, research, general practice, 
farmer organizations, companies, state 
agencies and leading animal scientists 
working with the dairy industry. 
The programme starts with a series of 
short courses on 14 May (limited number 
of seats available), followed by a welcome 
reception at Tivoli Gardens. On 15 and 
16 May, there will be parallel scientific 
sessions comprising a broad range of 
topics such as milking management, 
diagnostics, social science and molecular 
epidemiology. Key note lectures will be 
provided by leading scientists in many 
aspects of mastitis. The preliminary 
programme is as follows:
Please visit our website www.idfmasti-
tis2019.com for more information. Early 
bird registration opens on 15 December 
2018 through the website. Information 
about accommodation will also be made 
available on the website by the end of the 
year. Participation fee will be around 400 
Euro, half price for students and accompa-
nying persons. For sponsorship opportuni-
ties, contact Michael Farre at mifa@seges.
dk. There will also be a limited number of 
student awards, more information to follow.
There will be plenty of opportunities 
to network and exchange ideas for all 
professionals with a core interest in milk. 
And there will be time to enjoy the great 
city of Copenhagen. Please join us on 14 
to 16 May 2019. We are looking forward 
to seeing you!
Tuesday 14 May 2019
Preconference 
course
Preconference 
course
Preconference 
course
Preconference 
course
Preconference 
course
Preconference 
course
Preconference 
course
Preconference 
course
Diamond sponsor industrial seminar
Welcome reception at Tivoli Gardens
Wednesday 15 May 2019
Opening session: Mastitis management in an economic perspective
Diagnostics Udder hygiene
Decision support tools, modelling & 
economics Milk Quality
Social sciences and antimicrobial usage Small ruminants
Conference dinner at Circus Building (Copenhagen)
Thursday 16 May 2019
Advice and management Milking machines
Microbiota and molecular epidemiology Milking management
The dry period Mastitis manageme  nt
Closing session: Diagnostic methods for mastitis - Benefits for farmers and veterinarians
Friday 17 May 2019
Technical tour: Farm visit
Jaap Boes1, Chair, Organizing Committee 
and Morten Dam Rasmussen2, 
Chair, Scientific Committee
SEGES, Livestock Innovation, Denmark
 JBO@seges.dk
2018 IDF Animal Health Report • Issue N°1244
IDF WDS 2018: Session on Animal Health and Welfare
Under the main theme “Dairy for the Next 
Generation”, the IDF World Dairy Summit 
(WDS) 2018 will be held in Daejeon, South 
Korea, from the 15th to 19th of October 
2018. Many emerging issues and key 
aspects of dairy farming and industry will 
be discussed in the IDF WDS 2018 and it 
provide a dynamic and interactive platform 
for all the participants; exchanging novel 
technologies and knowledge, identifying 
a common agenda in dairy society and 
sharing innovative experiences on dairy 
farming.
During the Summit, the Animal Health 
and Welfare (AHW) conference will focus 
on a one health concept to achieve one 
healthy dairy world. The first session 
of the AHW conference will cover 
some emerging issues on infectious 
diseases in the current dairy farming, 
including paratuberculosis and the newly 
developing mastitis vaccines. The second 
session will present the current problems 
on antimicrobial resistance (AMR) in dairy 
farms, animals and dairy workers and how 
the AMR issues are managed by different 
countries. The third and fourth sessions 
will provide various insights on the 
improvement of animal health and welfare 
from the viewpoint of dairy customers and 
farmers from different countries. 
Nowadays, the world dairy sector 
is facing many challenges such as 
increasing productivity, improving supply 
and demand management systems, 
innovating distribution structures and 
increasing consumption. To successfully 
navigate such challenges, companies are 
investing in R&D and dairy farmers are 
paying greater attention to milk quality, 
eco-friendly practices and animal welfare. 
Government efforts also contribute to 
improving the dairy sector by focusing on 
“Many emerging issues 
and key aspects of dairy 
farming and industry will 
be discussed in the IDF 
WDS 2018 and it provide 
a dynamic and interactive 
platform for all the 
participants; exchanging 
novel technologies and 
knowledge, identifying 
a common agenda in 
dairy society and sharing 
innovative experiences 
on dairy farming.”
Jang W. Yoon
collaborations and support rooted in a one 
health-based approach.
To maintain good qualitative standards 
of milk and dairy products, dairy farmers 
and manufacturers should understand 
the complicated interactions between the 
human-animal ecosystems. In a recent 
study, for example, Lombardo et al. 
demonstrated how the development of an 
HACCP-like self-monitoring system with 
quantitative markers in critical points of 
the primary milk production chain, as well 
as in animals, is applicable for toxicant-
related zoonoses in daily milk production 
with a simultaneous health benefit on the 
human-animal ecosystems (1).
Chronologically, the term “One Health” 
has been originated from “One Medicine” 
which was coined in the 1960s by C. 
Schwabe, a veterinary scientist and 
epidemiologist at the University of 
California, Davis, who died in 2006 (2). He 
emphasized the outcomes and potential 
benefits of “One Medicine” as added value 
to public health, which was incapable 
of being achieved through disciplinary 
approaches alone (2). However, this term 
“One Medicine” includes the general 
science of all human and animal health 
and diseases without the disciplinary 
specialization common in both human and 
veterinary medicine. Thus, the concept of 
“One Medicine” has been extended to the 
concept of “One Health” in the 1980s, 
for sustainable development and/or 
healthy production of the human-animal 
ecosystems, wherever they coexist. In 
2008, the One Health Initiative Task Force 
has defined the term “One Health” as the 
collaborative effort of multiple disciplines 
working locally, nationally and globally to 
attain optimal health for people, animals 
and the environment (3)..
J.W. Yoon, PhD
College of Veterinary Medicine & Institute 
of Veterinary Science, Republic of Korea
 jwy706@kangwon.ac.kr
REFERENCES
1. Lombardo, A., Boselli, C., Amatiste, S., Ninci, S., 
Frazzoli, C., Dragone, R., De Rossi, A., Grasso, 
G., Mantovani, A. & Brajon, G.  (2017) From Inven-
tion to Innovation: Risk Analysis to Integrate One 
Health Technology in the Dairy Farm. Front Public 
Health. 2017, 5:302.
2. Zinsstag, J., Schelling, E., Wyss, K. & Mahamat, 
M.B. (2005) Potential of cooperation between hu-
man and animal health to strengthen health sys-
tems. Lancet. 2005, 366:2142.
3. “One Health: A New Professional Imperative” 
(2008) American Veterinary Medical Association. 
15 July 2008. 
45Past & Future IDF Conferences

© Dairy Farmers of Canada
INTERNATIONAL DAIRY FEDERATION 
70/B, Boulevard Auguste Reyers
1030 Brussels - Belgium 
Tel: +32 2 325 67 40
Fax: +32 2 325 67 41 
Email: info@fil-idf.org
  @fil-idf 
 www.fil-idf.org
